,"This is a citation overview for a set of 661 documents.",,,,,,,,,,,,
,,,,,,,,,,,,,
,"h index = 55 (Of the 661 documents considered for the h-Index, 55 have been cited at least 55 times.)",,,,,,,,,,,,
,Note: Scopus does not have complete citation information for articles published before 1996.  ,,,,,,,,,,,,
,,,,,,,,,,,,,
,,,,,,,<2010,2010,2011,2012,subtotal,>2012,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,9938,1130,1049,424,2603,0,12541
2009,"Government vs science over drug and alcohol policy","Nutt D.",01406736,"The Lancet",374, 9703,0,2,1,0,3,0,3
2009,"Early onset anxiolytic efficacy after a single dose of pregabalin: Double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model","Nutt D., Mandel F., Baldinetti F.",02698811,"Journal of Psychopharmacology",23, 8,0,3,5,0,8,0,8
2009,"Editorial: Prescribing antidepressants post Cipriani et al","Nutt D.J.",02698811,"Journal of Psychopharmacology",23, 8,0,1,1,1,3,0,3
2009,"Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls","Carhart-Harris R.L., Nutt D.J., Munafo M.R., Christmas D.M., Wilson S.J.",00333158,"Psychopharmacology",206, 2,0,1,2,1,4,0,4
2009,"Hypothermic responses to infection are inhibited by ?2- adrenoceptor agonists with possible clinical implications","Tolchard S., Burns P.A., Nutt D.J., Fitzjohn S.M.",00070912,"British Journal of Anaesthesia",103, 4,0,0,1,0,1,0,1
2009,"Brain opioid receptor binding in early abstinence from alcohol dependence and relationship to craving: An [11C]diprenorphine PET study","Williams T.M., Davies S.J.C., Taylor L.G., Daglish M.R.C., Hammers A., Brooks D.J., Nutt D.J., Lingford-Hughes A.",0924977X,"European Neuropsychopharmacology",19, 10,0,3,7,0,10,0,10
2009,"Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone","Argyropoulos S.V., Hicks J.A., Nash J.R., Bell C.J., Rich A.S., Nutt D.J., Wilson S.",09621105,"Journal of Sleep Research",18, 3,0,0,0,0,0,0,0
2009,"Identification of an imidazoline binding protein: Creatine kinase and an imidazoline-2 binding site","Kimura A., Tyacke R.J., Robinson J.J., Husbands S.M., Minchin M.C.W., Nutt D.J., Hudson A.L.",00068993,"Brain Research",1279, ,0,0,2,2,4,0,4
2009,"Effects of stressful life events, maternal depression and 5-HTTLPR genotype on emotional symptoms in pre-adolescent children","Araya R., Hu X., Heron J., Enoch M.-A., Evans J., Lewis G., Nutt D., Goldman D.",1552485X,"American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",150, 5,1,4,9,2,15,0,16
2009,"Effects of bupropion augmentation in escitalopram-resistant patients with major depressive disorder: An open-label, naturalistic study","Maron E., Eller T., Vasar V., Nutt D.J.",01606689,"Journal of Clinical Psychiatry",70, 7,0,1,3,0,4,0,4
2009,"Characterisation of the effects of caffeine on sleep in the rat: A potential model of sleep disruption","Paterson L.M., Wilson S.J., Nutt D.J., Hutson P.H., Ivarsson M.",02698811,"Journal of Psychopharmacology",23, 5,1,0,4,0,4,0,5
2009,"Serotonin and Sensitivity to Trauma-Related Exposure in Selective Serotonin Reuptake Inhibitors-Recovered Posttraumatic Stress Disorder","Corchs F., Nutt D.J., Hood S., Bernik M.",00063223,"Biological Psychiatry",66, 1,0,3,5,4,12,0,12
2009,"Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers","Paterson L.M., Nutt D.J., Ivarsson M., Hutson P.H., Wilson S.J.",02698811,"Journal of Psychopharmacology",23, 5,1,1,2,0,3,0,4
2009,"Beyond psychoanaleptics -can we improve antidepressant drug nomenclature?","Nutt D.J.",02698811,"Journal of Psychopharmacology",23, 4,0,1,2,1,4,0,4
2009,"Antidepressant-induced jitteriness/anxiety syndrome: Systematic review","Sinclair L.I., Christmas D.M., Hood S.D., Potokar J.P., Robertson A., Isaac A., Srivastava S., Nutt D.J., Davies S.J.C.",00071250,"British Journal of Psychiatry",194, 6,0,7,5,2,14,0,14
2009,"That warm fuzzy feeling: Brain serotonergic neurons and the regulation of emotion","Lowry C.A., Lightman S.L., Nutt D.J.",02698811,"Journal of Psychopharmacology",23, 4,1,3,7,0,10,0,11
2009,"Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression","Maron E., Tammiste A., Kallassalu K., Eller T., Vasar V., Nutt D.J., Metspalu A.",0924977X,"European Neuropsychopharmacology",19, 6,0,8,6,4,18,0,18
2009,"Current and former ecstasy users report different sleep to matched controls: A web-based questionnaire study","Carhart-Harris R.L., Nutt D.J., Munafo M., Wilson S.J.",02698811,"Journal of Psychopharmacology",23, 3,2,1,2,1,4,0,6
2009,"Cardiac slowing and acute tryptophan depletion: A comment on the paper by van der Veen et al.","Hood S.D., Davies S.J.C., Nutt D.J.",00333158,"Psychopharmacology",203, 4,0,0,0,0,0,0,0
2009,"Emotional symptoms in children: The effect of maternal depression, life events, and COMT genotype","Evans J., Xu K., Heron J., Enoch M.-A., Araya R., Lewis G., NicTimpson, Davies S., Nutt D., Goldman D.",1552485X,"American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",150, 2,1,1,1,1,3,0,4
2009,"A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO2 models of experimental human anxiety","Bailey J.E., Papadopoulos A., Seddon K., Nutt D.J.",02698811,"Journal of Psychopharmacology",23, 2,1,4,8,0,12,0,13
2009,"NAPSAQ-1: National Patient Sleep Assessment Questionnaire in depression","Paterson L.M., Nutt D.J., Wilson S.J.",13651501,"International Journal of Psychiatry in Clinical Practice",13, 1,0,1,0,0,1,0,1
2009,"P.3.07 Sleep changes during deep brain stimulation for treatment resistant depression: preliminary findings from a case study","Durant C., Wilson S., Paterson L., Nutt D., Gill S., Patel N., Malizia A.",0924977X,"European Neuropsychopharmacology",19, 1,0,0,0,0,0,0,0
2009,"P.3.03 A double-blind, placebo-controlled, parallel group study of the effect of Org 25935 on cognitive performance","Christmas D., Wilson S., Diaper A., Rich A., Udo do Haes J., Sjogren M., Nutt D.",0924977X,"European Neuropsychopharmacology",19, 1,0,0,0,0,0,0,0
2009,"Women with diarrhoea-predominant irritable bowel syndrome show an increased pressure response to 35% carbon dioxide stress challenge","Shufflebotham J., Wetherell M.A., Hince D., Hood S., Lightman S., Nutt D., Probert C., Potokar J.",10253890,"Stress",12, 1,1,1,1,1,3,0,4
2009,"Cape Town consensus on posttraumatic stress disorder.","Stein D.J., Cloitre M., Nemeroff C.B., Nutt D.J., Seedat S., Shalev A.Y., Wittchen H.U., Zohar J.",10928529,"CNS spectrums",14, 1,0,11,2,0,13,0,13
2009,"Equasy - An overlooked addiction with implications for the current debate on drug harms","Nutt D.J.",02698811,"Journal of Psychopharmacology",23, 1,2,3,4,0,7,0,9
2008,"Chapter 1.1 Introduction to the handbook on fear and anxiety","Blanchard R.J., Blanchard D.C., Griebel G., Nutt D.",15697339,"Handbook of Behavioral Neuroscience",17, ,0,0,0,0,0,0,0
2008,"Chapter 5.4 Principles and findings from human imaging of anxiety disorders","Malizia A.L., Nutt D.",15697339,"Handbook of Behavioral Neuroscience",17, ,0,0,0,0,0,0,0
2008,"Preface","Blanchard R.J., Blanchard D.C., Griebel G., Nutt D.",15697339,"Handbook of Behavioral Neuroscience",17, ,0,0,0,0,0,0,0
2008,"Chapter 5.1 Phenomenology of anxiety disorders","Nutt D., de Miguel B.G., Davies S.J.C.",15697339,"Handbook of Behavioral Neuroscience",17, ,0,0,0,0,0,0,0
2008,"Is the association of hypertension and panic disorder explained by clustering of autonomic panic symptoms in hypertensive patients?","Davies S.J.C., Jackson P.R., Lewis G., Hood S.D., Nutt D.J., Potokar J.P.",01650327,"Journal of Affective Disorders",111, 2-3,1,2,1,0,3,0,4
2008,"Potential novel anxiolytic drugs","Christmas D., Hood S., Nutt D.",13816128,"Current Pharmaceutical Design",14, 33,2,10,3,1,14,0,16
2008,"Sleep disorders as core symptoms of depression","Nutt D.J., Wilson S., Paterson L.",12948322,"Dialogues in Clinical Neuroscience",10, 3,4,11,6,4,21,0,25
2008,"Assessment of GABA A benzodiazepine receptor (GBzR) sensitivity in patients with alcohol dependence","Taylor C., Nash J., Rich A., Lingford-Hughes A., Nutt D., Potokar J.",07350414,"Alcohol and Alcoholism",43, 6,1,0,0,0,0,0,1
2008,"Introduction. The neurobiology of drug addiction: New vistas","Robbins T.W., Everitt B.J., Nutt D.J.",09628436,"Philosophical Transactions of the Royal Society B: Biological Sciences",363, 1507,0,0,0,0,0,0,0
2008,"Serotonin 5-HT 1A receptor binding in people with panic disorder: Positron emission tomography study","Nash J.R., Sargent P.A., Rabiner E.A., Hood S.D., Argyropoulos S.V., Potokar J.P., Grasby P.M., Nutt D.J.",00071250,"British Journal of Psychiatry",193, 3,6,15,10,6,31,0,37
2008,"Drug treatment of chronic insomnia - Dawn at the end of a long night?","Wilson S., Nutt D.",02698811,"Journal of Psychopharmacology",22, 7,4,0,0,0,0,0,4
2008,"Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: Consensus statement","Moller H.-J., Baldwin D.S., Goodwin G., Kasper S., Okasha A., Stein D.J., Tandon R., Versiani M., Malt U., Saletu B., Altamura A.C., Baron D., Bauer M., Belmaker R.H., Blier P., Boyer P., Bunney W.E., Burrows G., Fleischhacker W., Flores D., Gattaz W.F., Heinze G., Hindmarch I., Hippius H., Hoschl C., Kragh-Sorensen P., Lopez-Ibor J.J., Millet B., Min S.K., Monti J., Muller-Oerlinghausen B., Muller-Spahn F., Nutt D.J., Olie J.P., Paykel E.S., Racagni G., Renshaw P., Rosenberg R., Singh B., Vieta E., Zohar J.",09401334,"European Archives of Psychiatry and Clinical Neuroscience",258, 3,12,12,6,1,19,0,31
2008,"Mourning and melancholia revisited: Correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry","Carhart-Harris R.L., Mayberg H.S., Malizia A.L., Nutt D.",1744859X,"Annals of General Psychiatry",7, ,2,2,4,2,8,0,10
2008,"Relationship of neurotransmitters to the symptoms of major depressive disorder.","Nutt D.J.",15552101,"The Journal of clinical psychiatry",69, ,13,11,16,3,30,0,43
2008,"Understanding causal pathways: A response to the commentaries","Hickman M., Lingford-Hughes A., Bailey C., Macleod J., Nutt D., Henderson G.",09652140,"Addiction",103, 7,0,0,0,0,0,0,0
2008,"GABA-A receptors and the response to CO2 inhalation - A translational trans-species model of anxiety?","Bailey J.E., Nutt D.J.",00913057,"Pharmacology Biochemistry and Behavior",90, 1,0,1,6,0,7,0,7
2008,"Does alcohol increase the risk of overdose death: The need for a translational approach","Hickman M., Lingford-Hughes A., Bailey C., Macleod J., Nutt D., Henderson G.",09652140,"Addiction",103, 7,7,0,3,0,3,0,10
2008,"Brain dopamine response in human opioid addiction","Daglish M.R.C., Williams T.M., Wilson S.J., Taylor L.G., Eap C.B., Augsburger M., Giroud C., Brooks D.J., Myles J.S., Grasby P., Lingford-Hughes A.R., Nutt D.J.",00071250,"British Journal of Psychiatry",193, 1,2,3,4,1,8,0,10
2008,"Glutamate and cortisol - A critical confluence in PTSD?","Reul J.M.H.M., Nutt D.J.",02698811,"Journal of Psychopharmacology",22, 5,2,1,5,1,7,0,9
2008,"Establishing non-inferiority in treatment trials in psychiatry - Guidelines from an expert consensus meeting","Nutt D., Allgulander C., Lecrubier Y., Peters T., Wittchen U.",02698811,"Journal of Psychopharmacology",22, 4,5,1,0,1,2,0,7
2008,"Wine and drug evaluations: Lessons on making comparisons of noninferiority","Allgulander C., Nutt D.J.",02698811,"Journal of Psychopharmacology",22, 4,0,0,0,0,0,0,0
2008,"A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder","Allgulander C., Nutt D., Detke M., Erickson J., Spann M., Walker D., Ball S.G., Russell J.M.",02698811,"Journal of Psychopharmacology",22, 4,9,1,5,0,6,0,15
2008,"Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: A detailed analysis of gene networks and clinical phenotypes","Kerr J.R., Burke B., Petty R., Gough J., Fear D., Mattey D.L., Axford J.S., Dalgleish A.G., Nutt D.J.",00219746,"Journal of Clinical Pathology",61, 6,6,7,5,2,14,0,20
2008,"Reply to letter by Green, Marsden and Fone (2007) about Sessa and Nutt's editorial (MDMA: Baby with the bath water) in the November 2007 Journal","Sessa B., Nutt D.",02698811,"Journal of Psychopharmacology",22, 4,2,0,0,0,0,0,2
2008,"GENetic and clinical predictors of treatment response in depression: The GenPod randomised trial protocol","Thomas L., Mulligan J., Mason V., Tallon D., Wiles N., Cowen P., Nutt D., O'Donovan M., Sharp D., Peters T., Lewis G.",17456215,"Trials",9, ,0,0,2,1,3,0,3
2008,"Addiction: The clinical interface","Nutt D., Lingford-Hughes A.",00071188,"British Journal of Pharmacology",154, 2,2,3,2,0,5,0,7
2008,"Why does the world have such a 'down' on antidepressants?","Nutt D.J., Malizia A.L.",02698811,"Journal of Psychopharmacology",22, 3,2,3,2,0,5,0,7
2008,"Reply to OCD letter","Nutt D.J.",02698811,"Journal of Psychopharmacology",22, 3,0,0,0,0,0,0,0
2008,"Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis","Kerr J.R., Petty R., Burke B., Gough J., Fear D., Sinclair L.I., Mattey D.L., Richards S.C.M., Montgomery J., Baldwin D.A., Kellam P., Harrison T.J., Griffin G.E., Main J., Enlander D., Nutt D.J., Holgate S.T.",00221899,"Journal of Infectious Diseases",197, 8,14,14,8,3,25,0,39
2008,"Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokers","Hitsman B., MacKillop J., Lingford-Hughes A., Williams T.M., Ahmad F., Adams S., Nutt D.J., Munafo M.R.",00333158,"Psychopharmacology",196, 4,3,3,2,2,7,0,10
2008,"Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression","Trivedi M.H., Hollander E., Nutt D., Blier P.",01606689,"Journal of Clinical Psychiatry",69, 2,12,15,10,4,29,0,41
2008,"Reduced thalamic grey matter volume in opioid dependence is influenced by degree of alcohol use: A voxel-based morphometry study","Reid A.G., Daglish M.R.C., Kempton M.J., Williams T.M., Watson B., Nutt D.J., Lingford-Hughes A.R.",02698811,"Journal of Psychopharmacology",22, 1,3,0,0,1,1,0,4
2008,"Uncritical positive regard? Issues in the efficacy and safety of psychotherapy","Nutt D.J., Sharpe M.",02698811,"Journal of Psychopharmacology",22, 1,11,7,5,2,14,0,25
2007,"Blockade of alcohol's amnestic activity in humans by an ?5 subtype benzodiazepine receptor inverse agonist","Nutt D.J., Besson M., Wilson S.J., Dawson G.R., Lingford-Hughes A.R.",00283908,"Neuropharmacology",53, 7,16,11,9,7,27,0,43
2007,"Role of GABA in anxiety and depression","Kalueff A.V., Nutt D.J.",10914269,"Depression and Anxiety",24, 7,17,26,14,4,44,0,61
2007,"MDMA, politics and medical research: Have we thrown the baby out with the bathwater?","Sessa B., Nutt D.J.",02698811,"Journal of Psychopharmacology",21, 8,5,4,1,0,5,0,10
2007,"Which antidepressants have demonstrated superior efficacy? A review of the evidence","Montgomery S.A., Nutt D.J., Rouillon F., Schatzberg A.F., Thase M.E., Baldwin D.S., Blier P., Fineberg N.A., Kasper S., Lader M., Lam R.W., Lepine J.-P., Moller H.-J.",02681315,"International Clinical Psychopharmacology",22, 6,37,15,12,4,31,0,68
2007,"D-Cycloserine and performance under different states of anxiety in healthy volunteers","Bailey J.E., Papadopoulos A., Lingford-Hughes A., Nutt D.J.",00333158,"Psychopharmacology",193, 4,3,2,3,2,7,0,10
2007,"The other face of depression, reduced positive affect: The role of catecholamines in causation and cure","Nutt D., Demyttenaere K., Janka Z., Aarre T., Bourin M., Canonico P.L., Carrasco J.L., Stahl S.",02698811,"Journal of Psychopharmacology",21, 5,22,10,22,3,35,0,57
2007,"Management of insomnia: Treatments and mechanisms","Wilson S., Nutt D.",00071250,"British Journal of Psychiatry",191, 3,2,2,4,0,6,0,8
2007,"Low sensitivity of the positron emission tomography ligand [ 11C]diprenorphine to agonist opiates","Hume S.P., Lingford-Hughes A.R., Nataf V., Hirani E., Ahmad R., Davies A.N., Nutt D.J.",00223565,"Journal of Pharmacology and Experimental Therapeutics",322, 2,5,2,3,0,5,0,10
2007,"The effect of nicotine on striatal dopamine release in man: A [ 11C]raclopride PET study","Montgomery A.J., Lingford-Hughes A.R., Egerton A., Nutt D.J., Grasby P.M.",08874476,"Synapse",61, 8,13,7,2,3,12,0,25
2007,"Panic and hypertension: Brothers in arms through 5-HT?","Davies S.J., Lowry C.A., Nutt D.J.",02698811,"Journal of Psychopharmacology",21, 6,4,5,2,3,10,0,14
2007,"Reply from the editors [2]","Blier P., Nutt D.",02698811,"Journal of Psychopharmacology",21, 6,0,0,0,0,0,0,0
2007,"Seizures in a night club","King L.A., Nutt D.",01406736,"Lancet",370, 9583,0,1,2,0,3,0,3
2007,"The effect of 1-(4,5-dihydro-1H-imidazol-2-yl) isoquinoline on monoamine release and turnover in the rat frontal cortex","Abu Ghazaleh H., Lalies M.D., Husbands S.M., Nutt D.J., Hudson A.L.",03043940,"Neuroscience Letters",422, 2,1,0,0,0,0,0,1
2007,"Key concepts in psychopharmacology","Nutt D., Lingford-Hughes A.",14761793,"Psychiatry",6, 7,0,0,0,0,0,0,0
2007,"Antipsychotics","Hood S.D., Orr K.G.D., Nutt D.",14761793,"Psychiatry",6, 7,0,0,0,0,0,0,0
2007,"Anxiolytics","Sinclair L., Nutt D.",14761793,"Psychiatry",6, 7,1,0,3,0,3,0,4
2007,"Treatment of insomnia","Wilson S., Nutt D.",14761793,"Psychiatry",6, 7,1,0,1,0,1,0,2
2007,"Antidepressants","Nash J., Nutt D.",14761793,"Psychiatry",6, 7,0,3,0,1,4,0,4
2007,"Brain opioid receptor binding in early abstinence from opioid dependence: Positron emission tomography study","Williams T.M., Daglish M.R.C., Lingford-Hughes A., Taylor L.G., Hammers A., Brooks D.J., Grasby P., Myles J.S., Nutt D.J.",00071250,"British Journal of Psychiatry",191, JULY,2,2,1,0,3,0,5
2007,"Pharmacological treatment of bipolar disorder","Seddon K., Nutt D.",14761793,"Psychiatry",6, 7,2,0,0,0,0,0,2
2007,"Pharmacokinetics for psychiatrists","Davies S.J.C., Nutt D.",14761793,"Psychiatry",6, 7,0,0,0,0,0,0,0
2007,"Assessing drug-related harm - Authors' reply","Nutt D., King L., Saulsbury W., Blakemore C.",01406736,"Lancet",369, 9576,0,0,0,0,0,0,0
2007,"Rob Kerwin--an appreciation.","Nutt D.",02698811,"Journal of psychopharmacology (Oxford, England)",21, 3,0,0,0,1,1,0,1
2007,"A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers","Paterson L.M., Wilson S.J., Nutt D.J., Hutson P.H., Ivarsson M.",00333158,"Psychopharmacology",191, 4,5,1,5,1,7,0,12
2007,"Pharmacological treatment of panic disorder","Seddon K., Nutt D.",14761793,"Psychiatry",6, 5,0,0,0,0,0,0,0
2007,"Psychopharmacology of anxiety","Nash J., Nutt D.",14761793,"Psychiatry",6, 4,0,0,0,0,0,0,0
2007,"Development of a rational scale to assess the harm of drugs of potential misuse","Nutt D., King L.A., Saulsbury W., Blakemore C.",01406736,"Lancet",369, 9566,58,42,38,20,100,0,158
2007,"Consensus statement on the benefit to the community of ESEMeD (European study of the epidemiology of mental disorders) survey data on depression and anxiety","Nutt D.J., Kessler R.C., Alonso J., Benbow A., Lecrubier Y., Lepine J.-P., Mechanic D., Tylee A.",01606689,"Journal of Clinical Psychiatry",68, 2,6,1,4,0,5,0,11
2007,"Development and validation of the Generalized Anxiety Disorder Inventory (GADI)","Argyropoulos S.V., Ploubidis G.B., Wright T.S., Palm M.E., Hood S.D., Nash J.R., Taylor A.C., Forshall S.W., Anderson I.M., Nutt D.J., Potokar J.P.",02698811,"Journal of Psychopharmacology",21, 2,6,1,1,0,2,0,8
2007,"In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: Evidence for two distinct I2 binding sites","Paterson L.M., Tyacke R.J., Robinson E.S.J., Nutt D.J., Hudson A.L.",00283908,"Neuropharmacology",52, 2,3,0,0,1,1,0,4
2007,"Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: Disease mechanisms, a diagnostic test and specific treatments","Kerr J.R., Christian P., Hodgetts A., Langford P.R., Devanur L.D., Petty R., Burke B., Sinclair L.I., Richards S.C.M., Montgomery J., McDermott C.R., Harrison T.J., Kellam P., Nutt D.J., Holgate S.T., Honeybourne D., Smith A.P., Thomas M., Ayres J.G., Main J., Daymond T., Bansal A., Puri B.K., Morgan R., Peveler R.C., Axford J.S., Weir W., Enlander D., Chia J.K.",00219746,"Journal of Clinical Pathology",60, 2,8,5,3,0,8,0,16
2007,"A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers","Bailey J.E., Kendrick A., Diaper A., Potokar J.P., Nutt D.J.",02698811,"Journal of Psychopharmacology",21, 1,6,4,6,2,12,0,18
2007,"Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: Recommendations from the British Association for Psychopharmacology","Nutt D.J., Taylor E., Weiss M., Young S., Fone K., Asherson P., Bramble D., Hill P., Matthews K., Morris K.A., Santosh P., Sonuga-Barke E.",02698811,"Journal of Psychopharmacology",21, 1,38,11,11,3,25,0,63
2007,"Reply from the editor","Nutt D.",02698811,"Journal of Psychopharmacology",21, 1,0,0,0,0,0,0,0
2006,"Resolution of Sleepiness and Fatigue in Major Depressive Disorder: A Comparison of Bupropion and the Selective Serotonin Reuptake Inhibitors","Papakostas G.I., Nutt D.J., Hallett L.A., Tucker V.L., Krishen A., Fava M.",00063223,"Biological Psychiatry",60, 12,32,9,8,1,18,0,50
2006,"Human taste thresholds are modulated by serotonin and noradrenaline","Heath T.P., Melichar J.K., Nutt D.J., Donaldson L.F.",02706474,"Journal of Neuroscience",26, 49,17,8,5,4,17,0,34
2006,"Dopamine and social anxiety disorder","Robinson H.M., Hood S.D., Bell C.J., Nutt D.J.",15164446,"Revista Brasileira de Psiquiatria",28, 4,3,1,1,0,2,0,5
2006,"Anxiety and OCD - The chicken or the egg?","Nutt D., Malizia A.",02698811,"Journal of Psychopharmacology",20, 6,3,1,1,0,2,0,5
2006,"Acute tryptophan depletion alters gastrointestinal and anxiety symptoms in irritable bowel syndrome","Shufflebotham J., Hood S., Hendry J., Hince D.A., Morris K., Nutt D., Probert C., Potokar J.",00029270,"American Journal of Gastroenterology",101, 11,7,2,3,1,6,0,13
2006,"Understanding the neurobiology of comorbidity in anxiety disorders","Nutt D.J., Stein D.J.",10928529,"CNS Spectrums",11, 12,13,3,3,2,8,0,21
2006,"2-(4,5-Dihydroimidazol-2-yl)benzimidazoles as highly selective imidazoline I2/adrenergic ?2 receptor ligands","Saczewski F., Tabin P., Tyacke R.J., Maconie A., Saczewski J., Kornicka A., Nutt D.J., Hudson A.L.",09680896,"Bioorganic and Medicinal Chemistry",14, 19,4,0,1,1,2,0,6
2006,"Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function","Papadopoulos V., Zhang M.-R., Gavish M., Baraldi M., Guilarte T.R., Knudsen T.B., Lacapere J.-J., Lindemann P., Norenberg M.D., Nutt D., Weizman A.",01656147,"Trends in Pharmacological Sciences",27, 8,159,66,64,42,172,0,331
2006,"Tryptophan metabolism in the central nervous system: Medical implications","Ruddick J.P., Evans A.K., Nutt D.J., Lightman S.L., Rook G.A.W., Lowry C.A.",14623994,"Expert Reviews in Molecular Medicine",8, 20,30,15,16,5,36,0,66
2006,"Depleting serotonin enhances both cardiovascular and psychological stress reactivity in recovered patients with anxiety disorders","Davies S.J.C., Hood S.D., Argyropoulos S.V., Morris K., Bell C., Witchel H.J., Jackson P.R., Nutt D.J., Potokar J.P.",02710749,"Journal of Clinical Psychopharmacology",26, 4,14,3,2,4,9,0,23
2006,"The role of dopamine and norepinephrine in depression and antidepressant treatment","Nutt D.J.",01606689,"Journal of Clinical Psychiatry",67, 6,46,14,6,4,24,0,70
2006,"The role of dopamine and norepinephrine in depression and antidepressant treatment","Nutt D.J., Tylee A., Baldwin D.S., Clayton A.H., Elgie R., Lecrubier Y., Montejo A.L., Papakostas G.I., Souery D., Trivedi M.H.",01606689,"Journal of Clinical Psychiatry",67, 6,3,2,1,1,4,0,7
2006,"Generalized anxiety disorder: A comorbid disease","Nutt D., Argyropoulos S., Hood S., Potokar J.",0924977X,"European Neuropsychopharmacology",16, 2,13,6,3,5,14,0,27
2006,"A tale of two Es","Nutt D.",02698811,"Journal of Psychopharmacology",20, 3,14,3,1,0,4,0,18
2006,"Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram","Toru I., Shlik J., Maron E., Vasar V., Nutt D.J.",00333158,"Psychopharmacology",186, 1,5,2,0,0,2,0,7
2006,"Reply to commentaries","Nutt D.",02698811,"Journal of Psychopharmacology",20, 3,0,0,0,0,0,0,0
2006,"Alcohol alternatives - A goal for psychopharmacology?","Nutt D.J.",02698811,"Journal of Psychopharmacology",20, 3,3,0,0,0,0,0,3
2006,"GABAA receptors: Subtypes, regional distribution, and function","Nutt D.",15509389,"Journal of Clinical Sleep Medicine",2, 2,10,6,1,0,7,0,17
2006,"Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice","Anderson N.J., Seif I., Nutt D.J., Hudson A.L., Robinson E.S.J.",00223042,"Journal of Neurochemistry",96, 6,5,1,1,1,3,0,8
2006,"Imaging alcohol cue exposure in alcohol dependence using a PET 15O-H2O paradigm: Results from a pilot study","Lingford-Hughes A.R., Daglish M.R.C., Stevenson B.J., Feeney A., Pandit S.A., Wilson S.J., Myles J., Grasby P.M., Nutt D.J.",13556215,"Addiction Biology",11, 1,5,3,4,2,9,0,14
2006,"In vitro and ex vivo distribution of [3H]harmane, an endogenous ?-carboline, in rat brain","Anderson N.J., Tyacke R.J., Husbands S.M., Nutt D.J., Hudson A.L., Robinson E.S.J.",00283908,"Neuropharmacology",50, 3,9,2,2,1,5,0,14
2006,"Informed consent - A new approach to drug regulation?","Nutt D.J.",02698811,"Journal of Psychopharmacology",20, 1,1,0,0,0,0,0,1
2005,"Pharmacotherapy of anxiety.","Nash J.R., Nutt D.J.",01712004,"Handbook of experimental pharmacology.",, 169,2,0,0,1,1,0,3
2005,"Preparation, structure and affinity for imidazoline i2 receptors and-adrenoceptors of L-[(4,5-dihydro-imidazolidin-2-yl)imino]indan-2-ols","Kornicka A., Saczewski F., Tyacke R.J., Hudson A.L., Nutt D.J.",00016837,"Acta Poloniae Pharmaceutica - Drug Research",62, 6,0,0,0,0,0,0,0
2005,"Evidence-based guidelines for the pharmacological treatment of anxiety disorders: Recommendations from the British Association for Psychopharmacology","Baldwin D.S., Scott J., Wittchen H.-U., Anderson I.M., Nutt D.J., Bandelow B., Bond A., Davidson J.R.T., Den Boer J.A., Fineberg N.A., Knapp M.",02698811,"Journal of Psychopharmacology",19, 6,128,37,37,14,88,0,216
2005,"The use of sleep measures to compare a new 5HT 1A agonist with buspirone in humans","Wilson S.J., Bailey J.E., Rich A.S., Nash J., Adrover M., Tuornoux A., Nutt D.J.",02698811,"Journal of Psychopharmacology",19, 6,6,2,4,0,6,0,12
2005,"Is there cognitive impairement in clinically 'healthy' abstinent alcohol dependence?","Davies S.J.C., Pandit S.A., Feeney A., Stevenson B.J., Kerwin R.W., Nutt D.J., Marshall E.J., Boddington S., Lingford-Hughes A.",07350414,"Alcohol and Alcoholism",40, 6,20,5,7,5,17,0,37
2005,"Characterisation of imidazoline I2 binding sites in pig brain","Anderson N.J., Lupo P.A., Nutt D.J., Hudson A.L., Robinson E.S.J.",00142999,"European Journal of Pharmacology",519, 1-2,5,0,0,1,1,0,6
2005,"Dr Shipman's last legacy: E-surveillance of the medical profession","Nutt D.J.",02698811,"Journal of Psychopharmacology",19, 5,0,0,0,0,0,0,0
2005,"Bridging the preclinical - Clinical gap [1]","Nutt D.J., Lingford-Hughes A., Daglish M., Williams T., Taylor L., Wilson S., Davies S., Melichar J., Myles J.",15921638,"Heroin Addiction and Related Clinical Problems",7, 3,0,0,0,0,0,0,0
2005,"The uptake of a fluorescently labelled antisense oligonucleotide in vitro and in vivo","Robinson E.S.J., Nutt D.J., Jackson H.C., Hudson A.L.",01650270,"Journal of Neuroscience Methods",147, 1,0,0,0,0,0,0,0
2005,"A proof-of-concept study using [ 11C]flumazenil PET to demonstrate that pagoclone is a partial agonist","Lingford-Hughes A., Wilson S.J., Feeney A., Grasby P.G., Nutt D.J.",00333158,"Psychopharmacology",180, 4,12,2,1,1,4,0,16
2005,"Psychopharmacology: Editorial","Robbins T.W., Nutt D.J., De Wit H.",00333158,"Psychopharmacology",180, 4,0,0,0,0,0,0,0
2005,"GABA-benzodiazepine receptor function in alcohol dependence: A combined 11C-flumazenil PET and pharmacodynamic study","Lingford-Hughes A.R., Wilson S.J., Cunningham V.J., Feeney A., Stevenson B., Brooks D.J., Nutt D.J.",00333158,"Psychopharmacology",180, 4,9,3,1,2,6,0,15
2005,"Acute tryptophan depletion. Part II: Clinical effects and implications","Bell C.J., Hood S.D., Nutt D.J.",00048674,"Australian and New Zealand Journal of Psychiatry",39, 7,27,9,9,2,20,0,47
2005,"Comparison of alterations in c-fos and Egr-1 (zif268) expression throughout the rat brain following acute administration of different classes of antidepressant compounds","Slattery D.A., Morrow J.A., Hudson A.L., Hill D.R., Nutt D.J., Henry B.",0893133X,"Neuropsychopharmacology",30, 7,12,2,3,3,8,0,20
2005,"Foresight brain science, addiction and drugs project","Nutt D.J.",02698811,"Journal of Psychopharmacology",19, 4,0,0,0,0,0,0,0
2005,"Acute tryptophan depletion. Part I: Rationale and methodology","Hood S.D., Bell C.J., Nutt D.J.",00048674,"Australian and New Zealand Journal of Psychiatry",39, 7,33,13,6,2,21,0,54
2005,"Human functional neuroimaging connectivity research in dependence","Daglish M., Lingford-Hughes A., Nutt D.",03341763,"Reviews in the Neurosciences",16, 2,1,2,0,0,2,0,3
2005,"Dizziness produced by a potent 5HT 1A receptor agonist (eptapirone) is not due to postural hypotension [3]","Wilson S.J., Bailey J.E., Nutt D.J.",00333158,"Psychopharmacology",179, 4,2,1,1,0,2,0,4
2005,"Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers","Bailey J.E., Argyropoulos S.V., Kendrick A.H., Nutt D.J.",10914269,"Depression and Anxiety",21, 1,8,2,8,3,13,0,21
2005,"Making sense of GABAA receptor subtypes: Is a new nomenclature needed?","Nutt D.J.",02698811,"Journal of Psychopharmacology",19, 3,9,0,2,0,2,0,11
2005,"The pharmaceutical industry and psychiatric research - A marriage for richer...?","Nutt D.J.",09556036,"Psychiatric Bulletin",29, 3,0,0,0,0,0,0,0
2005,"Assessment and management of insomnia","Wilson S., Nutt D.",14702118,"Clinical Medicine, Journal of the Royal College of Physicians of London",5, 2,4,0,0,0,0,0,4
2005,"NICE: The National Institute of Clinical Excellence - or Eccentricity? Reflections on the Z-drugs as hypnotics","Nutt D.J.",02698811,"Journal of Psychopharmacology",19, 2,7,1,0,0,1,0,8
2005,"Gamma hydroxy butyrate abuse and dependency","Gonzalez A., Nutt D.J.",02698811,"Journal of Psychopharmacology",19, 2,34,3,7,3,13,0,47
2005,"Psychotherapy meets neuroscience (multiple letters) [1]","Nutt D., Brown E.",09556036,"Psychiatric Bulletin",29, 3,1,0,0,0,0,0,1
2005,"Death by tricyclic: The real antidepressant scandal?","Nutt D.J.",02698811,"Journal of Psychopharmacology",19, 2,14,1,2,1,4,0,18
2005,"Stimulants: Use and abuse in the treatment of attention deficit hyperactivity disorder","Fone K.C.F., Nutt D.J.",14714892,"Current Opinion in Pharmacology",5, 1,43,2,5,2,9,0,52
2005,"Estimation of endogenous noradrenaline release in rat brain in vivo using [3H]RX 821002","Tyacke R.J., Robinson E.S.J., Lalies M.D.M., Hume S.P., Hudson A.L., Nutt D.J.",08874476,"Synapse",55, 2,2,1,1,0,2,0,4
2005,"Synthesis of 2,3,5,6-tetrahydro-3H-imidazo[2,1-b] [1,3,5]benzotriazepines and their oxidative ring contraction into 1-(4,5-dihydro-1H-imidazol-2-yl)-1H- benzimidazoles","Saczewski F., Kobierska E., Tyacke R.J., Hudson A.L., Nutt D.J., Gdaniec M.",0014827X,"Farmaco",60, 2,2,0,0,0,0,0,2
2005,"Using [11C]diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: Clinical and preclinical studies","Melichar J.K., Lingford-Hughes A., Nutt D.J., Hume S.P., Williams T.M., Daglish M.R.C., Taylor L.G., Ahmad R., Malizia A.L., Brooks D.J., Myles J.S.",00223565,"Journal of Pharmacology and Experimental Therapeutics",312, 1,21,2,1,1,4,0,25
2005,"Overview of diagnosis and drug treatments of anxiety disorders","Nutt D.J.",10928529,"CNS Spectrums",10, 1,56,7,12,3,22,0,78
2005,"Cannabis antagonists: A new era of social psychopharmacology?","Nutt D.",02698811,"Journal of Psychopharmacology",19, 1,0,1,0,0,1,0,1
2005,"Discontinuation of Vioxx.","Nutt D.J.",1474547X,"Lancet",365, 9453,1,0,0,0,0,0,1
2005,"Synthesis and biological activities of novel 1,2,3,5-tetrahydroimidazo[2,1- b]quinazoline derivatives","Kornicka A., Saczewski F., Petrusewicz J., Rejdych A., Tyacke R.J., Hudson A.L., Nutt D.J.",01375083,"Polish Journal of Chemistry",79, 1,2,0,0,0,0,0,2
2005,"Discontinuation of Vioxx (multiple letters)","Kim P.S., Juni P., Reichenbach S., Dieppe P.A., Egger M., Mitchell J.A., Warner T.D., Nutt D.J., Reicin A.S., Lievre M., Abadie E., Garattini S., Bertele V., Nyberg J., McLean T.R., Boers M.",01406736,"Lancet",365, 9453,2,0,0,0,0,0,2
2004,"Harmane and harmalan are bioactive components of classical clonidine-displacing substance","Parker C.A., Nutt D.J., Crump M.P., Crosby J., Anderson N.J., Robinson E.S.J., Price R., Tyacke R.J., Husbands S.M., Dillon M.P., Eglen R.M., Hudson A.L.",00062960,"Biochemistry",43, 51,11,1,1,0,2,0,13
2004,"Update on posttraumatic stress disorder","Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J.",01606689,"Journal of Clinical Psychiatry",65, 1,0,0,0,0,0,0,0
2004,"New directions in GABAergic pharmacology of anxiety and depression","Kaluev A.V., Nutt D.J.",08692092,"Eksperimental'naya i Klinicheskaya Farmakologiya",67, 6,1,0,0,0,0,0,1
2004,"Structural and functional brain changes in posttraumatic stress disorder","Nutt D.J., Malizia A.L.",01606689,"Journal of Clinical Psychiatry",65, 1,62,6,2,2,10,0,72
2004,"Consensus statement update on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety","Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J., Marshall R.D., Nemeroff C.B., Shalev A.Y., Yehuda R.",01606689,"Journal of Clinical Psychiatry",65, 1,45,3,4,0,7,0,52
2004,"Erratum: The clinical use of buprenorphine in opiate addication: Evidence and practice (Acta Neuropsychiatrica (2004) 16 (246-274))","Law F.D., Myles J.D., Daglish M.R.C., Nutt D.J.",09242708,"Acta Neuropsychiatrica",16, 6,0,0,0,0,0,0,0
2004,"On the role of GABA in anxiety and depression","Kaluev A.V., Nutt D.J.",08692092,"Eksperimental'naya i Klinicheskaya Farmakologiya",67, 4,3,0,0,0,0,0,3
2004,"Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram","Wilson S.J., Bailey J.E., Rich A.S., Adrover M., Potokar J., Nutt D.J.",0924977X,"European Neuropsychopharmacology",14, 5,13,1,3,1,5,0,18
2004,"The clinical use of buprenorphine in opiate addiction: Evidence and practice","Law F.D., Myles J.S., Daglish M.R.C., Nutt D.J.",09242708,"Acta Neuropsychiatrica",16, 5,7,4,0,0,4,0,11
2004,"Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder","Argyropoulos S.V., Hood S.D., Adrover M., Bell C.J., Rich A.S., Nash J.R., Rich N.C., Witchel H.J., Nutt D.J.",00063223,"Biological Psychiatry",56, 7,30,9,1,2,12,0,42
2004,"Anxiety and depression: Individual entities or two sides of the same coin?","Nutt D.",13651501,"International Journal of Psychiatry in Clinical Practice",8, 1,5,5,5,1,11,0,16
2004,"Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: Recommendations from the British Association for Psychopharmacology","Lingford-Hughes A.R., Welch S., Nutt D.J.",02698811,"Journal of Psychopharmacology",18, 3,42,10,11,3,24,0,66
2004,"Orexin-A infusion in the locus ceruleus triggers norepinephrine (NE) release and NE-induced long-term potentiation in the dentate gyrus","Walling S.G., Nutt D.J., Lalies M.D., Harley C.W.",02706474,"Journal of Neuroscience",24, 34,22,8,6,3,17,0,39
2004,"Infecting the brain to stop addiction?","Nutt D., Lingford-Hughes A.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",101, 31,0,0,0,0,0,0,0
2004,"Treatment of insomnia","Wilson S., Nutt D.",14761793,"Psychiatry",3, 7,0,0,0,0,0,0,0
2004,"Antipsychotics","Hood S.D., Nutt D.",14761793,"Psychiatry",3, 7,0,0,0,0,0,0,0
2004,"Key concepts in psychopharmacology","Nutt D., Lingford-Hughes A.",14761793,"Psychiatry",3, 7,0,0,0,0,0,0,0
2004,"Anxiolytics","Taylor C., Nutt D.",14761793,"Psychiatry",3, 7,0,0,0,0,0,0,0
2004,"Pharmacokinetics for psychiatrists","Davies S.J., Nutt D.",14761793,"Psychiatry",3, 7,0,0,1,0,1,0,1
2004,"Antidepressants","Nash J., Nutt D.",14761793,"Psychiatry",3, 7,0,0,0,0,0,0,0
2004,"Pharmacological characterisation of novel ?2-adrenoceptor antagonists as potential brain imaging agents","Robinson E.S.J., Tyacke R.J., Finch L., Willmott G., Husbands S., Nutt D.J., Hudson A.L.",00283908,"Neuropharmacology",46, 6,4,0,0,0,0,0,4
2004,"Treatment of anxiety and depressive disorders in patients with cardiovascular disease","Davies S.J.C., Jackson P.R., Potokar J., Nutt D.J.",09598146,"British Medical Journal",328, 7445,16,1,0,1,2,0,18
2004,"Animal models for obsessive-compulsive disorders","Man J., Hudson A.L., Ashton D., Nutt D.J.",1570159X,"Current Neuropharmacology",2, 2,9,1,1,1,3,0,12
2004,"Psychopharmacology of anxiety","Nash J., Nutt D.J.",14761793,"Psychiatry",3, 4,0,1,0,0,1,0,1
2004,"The role of serotonin in panic: Evidence from tryptophan depletion studies","Pyle A.C., Argyropoulos S.V., Nutt D.J.",09242708,"Acta Neuropsychiatrica",16, 2,0,1,1,0,2,0,2
2004,"Evaluation of actigraphy and automated telephoned questionnaires to assess hypnotic effects in insomnia","Wilson S.J., Rich A.S., Rich N.C., Potokar J., Nutt D.J.",02681315,"International Clinical Psychopharmacology",19, 2,2,0,3,0,3,0,5
2004,"Imidazoline2 (I2) receptor- and ? 2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed rats","Finn D.P., Hudson A.L., Kinoshita H., Coventry T.L., Jessop D.S., Nutt D.J., Harbuz M.S.",02698811,"Journal of Psychopharmacology",18, 1,8,0,0,0,0,0,8
2004,"Some important changes","Nutt D.J.",02698811,"Journal of Psychopharmacology",18, 1,0,0,0,0,0,0,0
2004,"Acute carbon dioxide exposure in healthy adults: Evaluation of a novel means of investigating the stress response","Kaye J., Buchanan F., Kendrick A., Johnson P., Lowry C., Bailey J., Nutt D., Lightman S.",09538194,"Journal of Neuroendocrinology",16, 3,24,5,7,1,13,0,37
2004,"Invited review: The evolution of antidepressant mechanisms","Slattery D.A., Hudson A.L., Nutt D.J.",07673981,"Fundamental and Clinical Pharmacology",18, 1,41,7,7,0,14,0,55
2003,"Endogenous ?-Carbolines as Clonidine-Displacing Substances","Robinson E.S.J., Anderson N.J., Crosby J., Nutt D.J., Hudson A.L.",00778923,"Annals of the New York Academy of Sciences",1009, ,18,1,3,0,4,0,22
2003,"In Vivo Estimation of Imidazoline2 Binding Site Turnover","Paterson L.M., Robinson E.S.J., Nutt D.J., Hudson A.L.",00778923,"Annals of the New York Academy of Sciences",1009, ,5,0,0,0,0,0,5
2003,"Death and dependence: Current controversies over the selective serotonin reuptake inhibitors","Nutt D.J.",02698811,"Journal of Psychopharmacology",17, 4,44,2,1,3,6,0,50
2003,"Functional connectivity analysis of the neural circuits of opiate craving: ""more"" rather than ""different""?","Daglish M.R.C., Weinstein A., Malizia A.L., Wilson S., Melichar J.K., Lingford-Hughes A., Myles J.S., Grasby P., Nutt D.J.",10538119,"NeuroImage",20, 4,32,3,6,2,11,0,43
2003,"BU98008, a Highly Selective Imidazoline1-Receptor Ligand","Robinson E.S.J., Price R.E., Nutt D.J., Hudson A.L.",00778923,"Annals of the New York Academy of Sciences",1009, ,2,0,0,0,0,0,2
2003,"Future directions in substance dependence research","Nutt D., Lingford-Hughes A., Daglish M.",03036995,"Journal of Neural Transmission, Supplement",, 64,4,2,1,0,3,0,7
2003,"Initial Evaluation of Novel Selective Ligands for Imidazoline2 Receptors in Rat Whole Brain","Tyacke R.J., Saczewski F., Tabin P., Saczewski J., Nutt D.J., Hudson A.L.",00778923,"Annals of the New York Academy of Sciences",1009, ,1,0,0,0,0,0,1
2003,"Characterization of [3H]Harmane Binding to Rat Whole Brain Membranes","Anderson N.J., Robinson E.S.J., Husbands S.M., Delagrange P., Nutt D.J., Hudson A.L.",00778923,"Annals of the New York Academy of Sciences",1009, ,5,2,1,0,3,0,8
2003,"Identification of an I2 Binding Protein from Rabbit Brain","Kimura A., Tyacke R.J., Minchin M.C.W., Nutt D.J., Hudson A.L.",00778923,"Annals of the New York Academy of Sciences",1009, ,6,0,0,0,0,0,6
2003,"Brain imaging studies in human addicts","Daglish M.R.C., Nutt D.J.",0924977X,"European Neuropsychopharmacology",13, 6,13,1,0,0,1,0,14
2003,"Investigation of the Affinities of Two New ?-Carbolines for Rat Brain Imidazoline2 Receptors","Tyacke R.J., Lau A., Grella B., Glennon R.A., Nutt D.J., Hudson A.L.",00778923,"Annals of the New York Academy of Sciences",1009, ,0,0,0,0,0,0,0
2003,"Novel Ligands for the Investigation of Imidazoline Receptors and Their Binding Proteins","Hudson A.L., Kimura A., Nutt D.J., Tyacke R.J., Lalies M.D., Davies N., Finn D.P., Marti O., Robinson E., Husbands S., Minchin M.C.W.",00778923,"Annals of the New York Academy of Sciences",1009, ,6,1,2,3,6,0,12
2003,"Relationship between Imidazoline2 Sites and Monoamine Oxidase","Paterson L.M., Tyacke R.J., Nutt D.J., Hudson A.L.",00778923,"Annals of the New York Academy of Sciences",1009, ,5,0,0,1,1,0,6
2003,"Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism [1] (multiple letters)","Nash J.R., Wilson S.J., Potokar J.P., Nutt D.J., Onofrj M., Thomas A.",00283878,"Neurology",61, 8,6,3,2,0,5,0,11
2003,"2-(4,5-Dihydro-1H-imidazol-2-yl)indazole (indazim) derivatives as selective I2 imidazoline receptor ligands","Saczewski F., Hudson A.L., Tyacke R.J., Nutt D.J., Man J., Tabin P., Saczewski J.",09280987,"European Journal of Pharmaceutical Sciences",20, 2,12,1,2,1,4,0,16
2003,"Correlation of subjective and objective sleep measurements at different stages of the treatment of depression","Argyropoulos S.V., Hicks J.A., Nash J.R., Bell C.J., Rich A.S., Nutt D.J., Wilson S.J.",01651781,"Psychiatry Research",120, 2,27,2,3,1,6,0,33
2003,"Does the brain noradrenaline network mediate the effects of the CO 2 challenge? Reply to reviewers' comments","Bailey J.E., Argyropoulos S.V., Lightman S.L., Nutt D.J.",02698811,"Journal of Psychopharmacology",17, 3,0,0,0,0,0,0,0
2003,"The unhappy saga of 'happy pills'","Nutt D.J.",02698811,"Journal of Psychopharmacology",17, 3,3,0,1,1,2,0,5
2003,"Does the brain noradrenaline network mediate the effects of the CO 2 challenge?","Bailey J.E., Gorman J.M., Argyropoulos S.V., Lightman S.L., Nutt D.J., Griez E., Schruers K., Bellodi L., Caldirola D., Bertani A.",02698811,"Journal of Psychopharmacology",17, 3,25,6,5,2,13,0,38
2003,"Caffeine and central noradrenaline: Effects on mood, cognitive performance, eye movements and cardiovascular function","Smith A., Brice C., Nash J., Rich N., Nutt D.J.",02698811,"Journal of Psychopharmacology",17, 3,29,1,3,0,4,0,33
2003,"WCA Recommendations for the Long-Term Treatment of Obsessive-Compulsive Disorder in Adults","Greist J.H., Bandelow B., Hollander E., Marazziti D., Montgomery S.A., Nutt D.J., Okasha A., Swinson R.P., Zohar J.",10928529,"CNS Spectrums",8, 8,49,4,3,2,9,0,58
2003,"WCA Recommendations for the Long-Term Treatment of Posttraumatic Stress Disorder","Stein D.J., Bandelow B., Hollander E., Nutt D.J., Okasha A., Pollack M.H., Swinson R.P., Zohar J.",10928529,"CNS Spectrums",8, 8,16,0,3,0,3,0,19
2003,"WCA Recommendations for the Long-Term Treatment of Generalized Anxiety Disorder","Allgulander C., Bandelow B., Hollander E., Montgomery S.A., Nutt D.J., Okasha A., Pollack M.H., Stein D.J., Swinson R.P.",10928529,"CNS Spectrums",8, 8,58,6,4,2,12,0,70
2003,"WCA Recommendations for the Long-Term Treatment of Panic Disorder","Pollack M.H., Allgulander C., Bandelow B., Cassano G.B., Greist J.H., Hollander E., Nutt D.J., Okasha A., Swinson R.P.",10928529,"CNS Spectrums",8, 8,39,4,1,0,5,0,44
2003,"WCA Recommendations for the Long-Term Treatment of Social Phobia","Van Ameringen M., Stein D.J., Swinson R.P., Allgulander C., Bandelow B., Greist J.H., Hollander E., Montgomery S.A., Nutt D.J., Okasha A., Pollack M.H.",10928529,"CNS Spectrums",8, 8,26,2,1,1,4,0,30
2003,"A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients","Weinstein A., Feldtkeller B., Feeney A., Lingford-Hughes A., Nutt D.J.",13556215,"Addiction Biology",8, 2,12,0,0,0,0,0,12
2003,"British Association for Psychopharmacology consensus on the treatment of bipolar disorder","Nutt D.J.",02698811,"Journal of Psychopharmacology",17, 2,0,0,0,0,0,0,0
2003,"Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test","Finn D.P., Nutt D.J., Hudson A.L., Marti O., Harbuz M.S., Valles A., Belda X., Marquez C., Jessop D.S., Lalies M.D., Armario A.",00333158,"Psychopharmacology",167, 2,16,0,3,2,5,0,21
2003,"Increased sympathetic response to standing in panic disorder","Coupland N.J., Wilson S.J., Potokar J.P., Bell C., Nutt D.J.",01651781,"Psychiatry Research",118, 1,12,3,0,1,4,0,16
2003,"Addiction","Lingford-Hughes A.R., Davies S.J.C., McIver S., Williams T.M., Daglish M.R.C., Nutt D.J.",00071420,"British Medical Bulletin",65, ,23,3,1,2,6,0,29
2003,"New directions in the treatment of anxiety disorders","Hood S.D., Argyropoulos S.V., Nutt D.J.",13543776,"Expert Opinion on Therapeutic Patents",13, 4,7,0,0,0,0,0,7
2003,"Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers","Bell C., Wilson S., Rich A., Bailey J., Nutt D.",00333158,"Psychopharmacology",166, 2,8,0,1,0,1,0,9
2003,"Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test","Melichar J.K., Myles J.S., Eap C.B., Nutt D.J.",13556215,"Addiction Biology",8, 1,8,2,0,1,3,0,11
2003,"Brain imaging studies in human addicts","Daglish M.R.C., Nutt D.J.",0924977X,"European Neuropsychopharmacology",13, 1,10,2,2,1,5,0,15
2003,"Maintenance buprenorphine for opioid users","Law F.D., Nutt D.J.",01406736,"Lancet",361, 9358,7,0,0,0,0,0,7
2003,"Psychotropic drugs, cardiac arrhythmia, and sudden death","Witchel H.J., Hancox J.C., Nutt D.J.",02710749,"Journal of Clinical Psychopharmacology",23, 1,84,10,10,3,23,0,107
2003,"Antipsychotics, HERG and sudden death [2]","Witchel H.J., Hancox J.C., Nutt D.J., Wilson S.",00071250,"British Journal of Psychiatry",182, ,5,1,0,0,1,0,6
2003,"Neurobiology of addiction and implications for treatment","Lingford-Hughes A., Nutt D.",00071250,"British Journal of Psychiatry",182, ,32,4,4,0,8,0,40
2003,"Naloxone displacement at opioid receptor sites measured in vivo in the human brain","Melichar J.K., Nutt D.J., Malizia A.L.",00142999,"European Journal of Pharmacology",459, 2-3,4,3,2,0,5,0,9
2002,"Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood","Wilson S.J., Bailey J.E., Alford C., Weinstein A., Nutt D.J.",02698811,"Journal of Psychopharmacology",16, 4,12,4,3,1,8,0,20
2002,"Generalized anxiety disorder: Comorbidity, comparative biology and treatment","Nutt D.J., Ballenger J.C., Sheehan D., Wittchen H.-U.",14611457,"International Journal of Neuropsychopharmacology",5, 4,40,4,6,3,13,0,53
2002,"The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy","Bell C., Vanderlinden H., Hiersemenzel R., Otoul C., Nutt D., Wilson S.",09621105,"Journal of Sleep Research",11, 3,21,1,5,1,7,0,28
2002,"Venlafaxine: a new class of antidepressant.","Hardy J., Argyropoulos S., Nutt D.J.",14623935,"Hospital medicine (London, England : 1998)",63, 9,4,1,0,0,1,0,5
2002,"Distribution of [3H]BU224, a selective imidazoline I2 binding site ligand, in rat brain","Robinson E.S.J., Tyacke R.J., Nutt D.J., Hudson A.L.",00142999,"European Journal of Pharmacology",450, 1,9,1,0,3,4,0,13
2002,"Imaging the GABA-benzodiazepine receptor subtype containing the ?-5-subunit in vivo with [11C]Ro15 4513 positron emission tomography","Lingford-Hughes A., Hume S.P., Feeney A., Hirani E., Osman S., Cunningham V.J., Pike V.W., Brooks D.J., Nutt D.J.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",22, 7,28,3,0,2,5,0,33
2002,"Tolerability and safety aspects of mirtazapine","Nutt D.J.",08856222,"Human Psychopharmacology",17, 1,27,5,2,1,8,0,35
2002,"5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline2 binding site ligand: In vitro and in vivo characterisation in rat brain","Tyacke R.J., Robinson E.S.J., Nutt D.J., Hudson A.L.",00283908,"Neuropharmacology",43, 1,8,0,0,1,1,0,9
2002,"Inhalation of 35% CO2 results in activation of the HPA axis in healthy volunteers","Argyropoulos S.V., Bailey J.E., Hood S.D., Kendrick A.H., Rich A.S., Laszlo G., Nash J.R., Lightman S.L., Nutt D.J.",03064530,"Psychoneuroendocrinology",27, 6,36,5,7,1,13,0,49
2002,"Imidazoline2 (I2) binding site- and ?2-adrenoceptor-mediated modulation of central noradrenergic and HPA axis function in control rats and chronically stressed rats with adjuvant-induced arthritis","Finn D.P., Lalies M.D., Harbuz M.S., Jessop D.S., Hudson A.L., Nutt D.J.",00283908,"Neuropharmacology",42, 7,9,0,0,0,0,0,9
2002,"Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression","Hicks J.A., Argyropoulos S.V., Rich A.S., Nash J.R., Bell C.J., Edwards C., Nutt D.J., Wilson S.J.",00071250,"British Journal of Psychiatry",180, JUNE,42,2,7,0,9,0,51
2002,"N1?-fluoroethyl-naltrindole (BU97001) and N1?-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential ?-opioid receptor PET ligands","Tyacke R.J., Robinson E.S.J., Schnabel R., Lewis J.W., Husbands S.M., Nutt D.J., Hudson A.L.",09698051,"Nuclear Medicine and Biology",29, 4,4,1,0,0,1,0,5
2002,"Long-term treatment strategies in anxiety disorders.","Allgulander C., Hirschfeld R.M., Nutt D.J.",00485764,"Psychopharmacology bulletin",36, ,6,1,2,0,3,0,9
2002,"Mechanism of action of antidepressants.","Artigas F., Nutt D.J., Shelton R.",00485764,"Psychopharmacology bulletin",36, ,26,3,1,1,5,0,31
2002,"Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine","Bell C., Forshall S., Adrover M., Nash J., Hood S., Argyropoulos S., Rich A., Nutt D.J.",02698811,"Journal of Psychopharmacology",16, 1,45,6,2,1,9,0,54
2002,"Conflict of interest and the British Journal of Psychiatry [1] (multiple letters)","Wright I.C., Thase M.E., Jackson G., Brown T., Butler J., Cowen P., Freeman C., Freeman H., Gask L., Kassianos G., Kirby A., Koppel S., Nutt D., Shaw P., Vardy C., Wilkinson G.",00071250,"British Journal of Psychiatry",180, ,2,0,0,0,0,0,2
2002,"A new vision for the Journal of Psychopharmacology","Nutt D.J., Sarter M., Bailey J.",02698811,"Journal of Psychopharmacology",16, 1,0,0,0,0,0,0,0
2002,"Treating anxiety complicated by substance misuse","Lingford-Hughes A., Potokar J., Nutt D.",13555146,"Advances in Psychiatric Treatment",8, 2,1,0,0,0,0,0,1
2002,"The neuropharmacology of serotonin and noradrenaline in depression","Nutt D.J.",02681315,"International Clinical Psychopharmacology",17, 1,73,12,9,0,21,0,94
2001,"Investigation of the sleep electrocorticogram of the common marmoset (Callithrix jacchus) using radiotelemetry","Crofts H.S., Wilson S., Muggleton N.G., Nutt D.J., Scott E.A.M., Pearce P.C.",13882457,"Clinical Neurophysiology",112, 12,11,0,1,0,1,0,12
2001,"New insights into the role of the GABAA-benzodiazepine receptor in psychiatric disorder","Nutt D.J., Malizia A.L.",00071250,"British Journal of Psychiatry",179, ,97,12,6,6,24,0,121
2001,"Imidazoline receptors and their role in depression","Hudson A.L., Nutt D.J., Husbands S.M.",1071894X,"Pharmaceutical News",8, 3,12,0,0,1,1,0,13
2001,"A proposed algorithm for improved recognition and treatment of the depression/anxiety spectrum in primary care","Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J.",15235998,"Primary Care Companion to the Journal of Clinical Psychiatry",3, 2,10,1,0,0,1,0,11
2001,"Tryptophan depletion as a clinical tool: Current status and future directions","Abrams J.K., Bell C.J., Nutt D.J.",13651501,"International Journal of Psychiatry in Clinical Practice",5, 4,0,0,0,0,0,0,0
2001,"Brain function in social anxiety disorder","Argyropoulos S.V., Bell C.J., Nutt D.J.",0193953X,"Psychiatric Clinics of North America",24, 4,12,3,0,0,3,0,15
2001,"Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects","Daglish M.R.C., Weinstein A., Malizia A.L., Wilson S., Melichar J.K., Britten S., Brewer C., Lingford-Hughes A., Myles J.S., Grasby P., Nutt D.J.",0002953X,"American Journal of Psychiatry",158, 10,66,5,6,1,12,0,78
2001,"?-carboline binding to imidazoline receptors","Husbands S.M., Glennon R.A., Gorgerat S., Gough R., Tyacke R., Crosby J., Nutt D.J., Lewis J.W., Hudson A.L.",03768716,"Drug and Alcohol Dependence",64, 2,53,9,9,1,19,0,72
2001,"Crossover trial of pagoclone and placebo in patients with DSM-IV panic disorder","Sandford J., Forshall S., Bell C., Argyropoulos S., Rich A., Orlando K.J.D., Gammans R.E., Nutt D.J.",02698811,"Journal of Psychopharmacology",15, 3,20,0,1,2,3,0,23
2001,"Effects of contextual priming on reactions to craving and withdrawal stimuli in alcohol-dependent participants","Feldtkeller B., Weinstein A., Cox W.M., Nutt D.",10641297,"Experimental and Clinical Psychopharmacology",9, 3,7,0,0,0,0,0,7
2001,"Arthritis and serotonergic antidepressants [4]","Hood S.D., Argyropoulos S.V., Nutt D.J.",02710749,"Journal of Clinical Psychopharmacology",21, 4,8,0,0,0,0,0,8
2001,"Consensus statement on transcultural issues in depression and anxiety from the international consensus group on depression and anxiety","Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J., Kirmayer L.J., Lepine J.-P., Lin K.-M., Tajima O., Ono Y.",01606689,"Journal of Clinical Psychiatry",62, 13,27,8,2,2,12,0,39
2001,"Generalized anxiety disorder: Nature and course","Nutt D.J., Wittchen H.-U., Ballenger J.C., Davidson J.R.T., Borkovec T.D., Lecrubier Y., Stein D.J., Hoyer J.",01606689,"Journal of Clinical Psychiatry",62, 11,95,14,13,1,28,0,123
2001,"Neurobiological mechanisms in generalized anxiety disorder","Nutt D.J., Stein D.J., Lecrubier Y., Wittchen H.-U., Ballenger J.C., Borkovec T.D., Davidson J.R.T.",01606689,"Journal of Clinical Psychiatry",62, 11,58,6,6,0,12,0,70
2001,"Consensus statement on generalized anxiety disorder from the international consensus group on depression and anxiety","Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J., Borkovec T.D., Rickels K., Stein D.J., Wittchen H.-U.",01606689,"Journal of Clinical Psychiatry",62, 11,127,9,10,5,24,0,151
2001,"Pharmacotherapy of generalized anxiety disorder","Davidson J.R.T., Ballenger J.C., Lecrubier Y., Rickels K., Borkovec T.D., Stein D.J., Nutt D.J.",01606689,"Journal of Clinical Psychiatry",62, 11,55,1,3,0,4,0,59
2001,"Tryptophan depletion and its implications for psychiatry","Bell C., Abrams J., Nutt D.",00071250,"British Journal of Psychiatry",178, ,99,9,12,5,26,0,125
2001,"Consensus statement on depression, anxiety, and cardiovascular disease","Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J., Roose S.P., Sheps D.S.",01606689,"Journal of Clinical Psychiatry",62, 8,23,1,1,1,3,0,26
2001,"Consensus statement on depression, anxiety, and functional gastrointestinal disorders","Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J., Lydiard R.B., Mayer E.A.",01606689,"Journal of Clinical Psychiatry",62, 8,14,2,1,0,3,0,17
2001,"Consensus statement on depression, anxiety, and oncology","Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J., Jones R.D., Berard R.M.F.",01606689,"Journal of Clinical Psychiatry",62, 8,24,4,5,1,10,0,34
2001,"Cardiovascular reflexes during treatment of social phobia with moclobemide","Coupland N.J., Bell C., Potokar J.P., Bailey J.E., Nutt D.J.",13651501,"International Journal of Psychiatry in Clinical Practice",5, 1,0,0,0,0,0,0,0
2001,"Social phobia: Illness or illusion?","Argyropoulos S.V., Hood S.D., Nutt D.J.",0001690X,"Acta Psychiatrica Scandinavica",103, 4,5,0,2,0,2,0,7
2001,"Selective ?-opioid receptor ligands: Potential PET ligands based on naltrindole","Clayson J., Jales A., Tyacke R.J., Hudson A.L., Nutt D.J., Lewis J.W., Husbands S.M.",0960894X,"Bioorganic and Medicinal Chemistry Letters",11, 7,12,0,1,0,1,0,13
2001,"Venlafaxine occupation at the noradrenaline reuptake site: In-vivo determination in healthy volunteers","Melichar J., Haida A., Rhodes C., Reynolds A.H., Nutt D.J., Malizia A.",02698811,"Journal of Psychopharmacology",15, 1,15,1,1,0,2,0,17
2001,"Epidemiology of severe insomnia and its consequences in Germany","Hajak G., Bianchi M., Boichut D., Crowe C., Hajak G., Hetta J., Hoffmann G., Jenkinson C., Leger D., Nutt D.J., Wilson S.",09401334,"European Archives of Psychiatry and Clinical Neuroscience",251, 2,78,7,11,4,22,0,100
2001,"Addiction and withdrawal - Current views","Melichar J.K., Daglish M.R.C., Nutt D.J.",14714892,"Current Opinion in Pharmacology",1, 1,22,2,1,0,3,0,25
2001,"Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release","Okada M., Nutt D.J., Murakami T., Zhu G., Kamata A., Kawata Y., Kaneko S.",02706474,"Journal of Neuroscience",21, 2,61,1,4,3,8,0,69
2001,"Current status of anxiolytic drugs","Pandit S.A., Argyropoulos S., Nutt D.J.",13552570,"Primary Care Psychiatry",7, 1,1,0,0,0,0,0,1
2000,"The processing of automatic thoughts of drug use and craving in opiate-dependent individuals","Weinstein A.M., Feldtkeller B.T., Lawa F., Myles J., Nutt D.J.",10641297,"Experimental and Clinical Psychopharmacology",8, 4,8,0,0,0,0,0,8
2000,"Treatment of depression and concomitant anxiety","Nutt D.",0924977X,"European Neuropsychopharmacology",10, 4,25,1,0,1,2,0,27
2000,"The psychobiology of anxiolytic drugs - Part 2: Pharmacological treatments of anxiety","Argyropoulos S.V., Sandford J.J., Nutt D.J.",01637258,"Pharmacology and Therapeutics",88, 3,50,6,2,4,12,0,62
2000,"Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers","Wilson S., Bailey J.E., Alford C., Nutt D.J.",02698811,"Journal of Psychopharmacology",14, 4,10,1,1,0,2,0,12
2000,"The psychobiology of anxiolytic drugs - Part 1: Basic neurobiology","Sandford J.J., Argyropoulos S.V., Nutt D.J.",01637258,"Pharmacology and Therapeutics",88, 3,42,1,4,1,6,0,48
2000,"5-HT1A receptor binding in panic disorder; comparison with depressive disorder and healthy volunteers using PET and [11C]WAY-100635","Sargent P., Nash J., Hood S., Rabiner E., Messa C., Cowen P., Nutt D., Grasby P.",10538119,"NeuroImage",11, 5,2,0,0,0,0,0,2
2000,"Impulsiveness, serotonin genes and repetition of deliberate self-harm (DSH)","Evans J., Reeves B., Platt H., Leibenau A., Goldman D., Jefferson K., Nutt D.",00332917,"Psychological Medicine",30, 6,33,2,2,3,7,0,40
2000,"Isolation of RP-HPLC pure clonidine-displacing substance from NG108-15 cells","Parker C.A., Hudson A.L., Nutt D.J., Dillon M.P., Eglen R.M., Crosby J.",00142999,"European Journal of Pharmacology",387, 1,5,0,0,0,0,0,5
2000,"Substance P antagonists: Novel agents in the treatment of depression","Argyropoulos S.V., Nutt D.J.",13543784,"Expert Opinion on Investigational Drugs",9, 8,24,1,1,0,2,0,26
2000,"Agents in development for anxiety disorders: Current status and future potential","Hood S.D., Argyropoulos S.V., Nutt D.J.",11727047,"CNS Drugs",13, 6,10,0,0,0,0,0,10
2000,"Sleep changes during long-term treatment of depression with fluvoxamine - A home-based study","Wilson S.J., Bell C., Coupland N.J., Nutt D.J.",00333158,"Psychopharmacology",149, 4,25,2,2,1,5,0,30
2000,"GABA(A) benzodiazepine receptor (GBzR) sensitivity: Test-retest reliability in normal volunteers","Potokar J., Nash J., Sandford J., Rich A., Nutt D.",08856222,"Human Psychopharmacology",15, 4,1,0,0,0,0,0,1
2000,"Pavlovian aversive and appetitive odor conditioning in humans: Subjective, peripheral, and electrocortical changes","Lingford-Hughes A., Nutt D.",09517367,"Current Opinion in Psychiatry",13, 3,1,0,0,0,0,0,1
2000,"Evaluation of [O-methyl-11C]RS.15385-197 as a positron emission tomography radioligand for central ?2-adrenoceptors","Hume S.P., Nutt D.J., Pike V.W., Hirani E., Opacka-Juffry J., Osman S., Myers R., Gunn R.N., McCarron J.A., Clark R.D., Melichar J.",03406997,"European Journal of Nuclear Medicine",27, 5,8,2,0,0,2,0,10
2000,"Behavioural and physiological effects induced by an infusion of antisense to ?(2D)-adrenoceptors in the rat","Robinson E.S.J., Nutt D.J., Jackson H.C., Hudson A.L.",00071188,"British Journal of Pharmacology",130, 1,3,0,0,0,0,0,3
2000,"Amphetamine misuse and social phobia [2]","Williams K., Argyropoulos S., Nutt D.J.",0002953X,"American Journal of Psychiatry",157, 5,4,0,0,0,0,0,4
2000,"Impulsiveness and the prolactin response to d-fenfluramine","Evans J., Platts H., Lightman S., Nutt D.",00333158,"Psychopharmacology",149, 2,21,2,2,1,5,0,26
2000,"Chest pain: Panic attack or heart attack?","Potokar J.P., Nutt D.J.",13685031,"International Journal of Clinical Practice",54, 2,11,0,1,0,1,0,12
2000,"Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety","Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J., Edna B F., Kessler R.C., McFarlane A.C., Shalev A.Y.",01606689,"Journal of Clinical Psychiatry",61, 5,157,13,8,0,21,0,178
2000,"The psychobiology of posttraumatic stress disorder","Nutt D.J.",01606689,"Journal of Clinical Psychiatry",61, 5,50,1,1,1,3,0,53
2000,"Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 1993 British Association for Psychopharmacology guidelines","Anderson I.M., Nutt D.J., Deakin J.F.W.",02698811,"Journal of Psychopharmacology",14, 1,200,16,8,4,28,0,228
2000,"Probes for imidazoline binding sites: Synthesis and evaluation of a selective, irreversible I2 ligand","Coates P.A., Grundt P., Robinson E.S.J., Nutt D.J., Tyacke R., Hudson A.L., Lewis J.W., Husbands S.M.",0960894X,"Bioorganic and Medicinal Chemistry Letters",10, 6,9,0,1,1,2,0,11
2000,"Desipramine binding to noradrenaline reuptake sites in cardiac sympathetic neurons in man in vivo","Malizia A.L., Melichar J.K., Rhodes C.G., Haida A., Reynolds A.H., Jones T., Nutt D.J.",00142999,"European Journal of Pharmacology",391, 3,5,1,0,0,1,0,6
2000,"Flumazenil challenge in social phobia","Coupland N.J., Bell C., Potokar J.P., Dorkins E., Nutt D.J.",10914269,"Depression and Anxiety",11, 1,14,1,1,0,2,0,16
2000,"New directions in anxiety: OCD spectrum disorders","Nutt D.J.",10928529,"CNS Spectrums",5, 6,0,0,0,0,0,0,0
1999,"Evaluation of severe insomnia in the general population - Implications for the management of insomnia: The UK perspective","Nutt D.J., Wilson S.",02698811,"Journal of Psychopharmacology",13, 4,4,0,0,0,0,0,4
1999,"Guest Editorial: Ten years of progress in understanding insomnia, 1988 to 1998","Nutt D.J., Doble A.",02698811,"Journal of Psychopharmacology",13, 4,0,0,0,0,0,0,0
1999,"BAP Symposium on Imaging: Brain Function and Drug Action: The imaging science of PET","Nutt D.J.",02698811,"Journal of Psychopharmacology",13, 4,0,0,0,0,0,0,0
1999,"Evaluation of severe insomnia in the general population: Results of a European multinational survey","Chevalier H., Los F., Boichut D., Bianchi M., Nutt D.J., Hajak G., Hetta J., Hoffmann G., Crowe C.",02698811,"Journal of Psychopharmacology",13, 4,86,8,5,1,14,0,100
1999,"Behavioral, neuroendocrine, and cardiovascular response to flumazenil: No evidence for an altered benzodiazepine receptor sensitivity in panic disorder (multiple letters) [1]","Potokar J., Lawson C., Wilson S., Nutt D., Strohle A., Kellner M., Holsborer F., Wiedemann K.",00063223,"Biological Psychiatry",46, 12,3,0,0,0,0,0,3
1999,"Guidelines for the management of social phobia/social anxiety disorder","Nutt D., Baldwin D., Beaumont G., Bell C., Denny C., Knapp M., Maxwell R., McNicholas F., Wells A.",13552570,"Primary Care Psychiatry",5, 4,2,0,0,0,0,0,2
1999,"A case of reversal of treatment-resistant depression after almost 30 years of symptoms","Argyropoulos S.V., Wheeler A., Nutt D.J.",13651501,"International Journal of Psychiatry in Clinical Practice",3, 4,1,0,0,0,0,0,1
1999,"The use of benzodiazepines in anxiety and other disorders","Argyropoulos S.V., Nutt D.J.",0924977X,"European Neuropsychopharmacology",9, 6,43,3,1,1,5,0,48
1999,"In vitro and in vivo approaches to the characterization of the ?1-adrenoceptor","Hudson A.L., Robinson E.S.J., Lalies M.D., Tyacke R.J., Jackson H.C., Nutt D.J.",01441795,"Journal of Autonomic Pharmacology",19, 6,15,2,2,0,4,0,19
1999,"Paroxetine and its uses in psychiatry","Bell C., Nutt D.",14623935,"Hospital Medicine",60, 5,1,0,0,0,0,0,1
1999,"Vitamin C, Mood and Cognitive Functioning in the Elderly","Smith A.P., Clark R.E., Nutt D.J., Haller J., Hayward S.G., Perry K.",1028415X,"Nutritional Neuroscience",2, 4,8,1,1,0,2,0,10
1999,"A PET study of cerebral blood flow changes in opiate craving","Daglish M., Weinstein A., Malizia A., Myles J., Grasby P.M., Nutt D.",10538119,"NeuroImage",9, 6,0,0,0,0,0,0,0
1999,"Autoradiographical and behavioural effects of a chronic infusion of antisense to the ?(2D)-adrenoceptor in the rat","Robinson E.S.J., Nutt D.J., Hall L., Jackson H.C., Hudson A.L.",00071188,"British Journal of Pharmacology",128, 3,15,1,0,0,1,0,16
1999,"Treatment of cluster headache with mirtazapine [1]","Nutt D., Law J.",00178748,"Headache",39, 8,4,1,0,0,1,0,5
1999,"A depressed man requesting St John's wort.","Ernst E., Gerada C., Hood S., Nutt D.",00326518,"Practitioner",243, 1604,0,0,0,0,0,0,0
1999,"Assessment of GABA(A) benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines","Potokar J., Coupland N., Wilson S., Rich A., Nutt D.",00333158,"Psychopharmacology",146, 2,6,1,0,0,1,0,7
1999,"Anti-oxidant vitamins and mental performance of the elderly","Smith A., Clark R., Nutt D., Haller J., Hayward S., Perry K.",08856222,"Human Psychopharmacology",14, 7,14,2,0,1,3,0,17
1999,"Effects of the common cold on subjective alertness, reaction time, and eye movements","Smith A., Rich N., Sturgess W., Brice C., Collison C., Bailey J., Wilson S., Nutt D.",02698803,"Journal of Psychophysiology",13, 3,1,0,0,0,0,0,1
1999,"The neuropharmacology of serotonin and noradrenaline in depression","Feeney A., Nutt D.J.",13651501,"International Journal of Psychiatry in Clinical Practice",3, 2,6,0,0,0,0,0,6
1999,"Care of depressed patients with anxiety symptoms","Nutt D.J.",01606689,"Journal of Clinical Psychiatry",60, 17,39,1,0,0,1,0,40
1999,"Home cage presentation of complex discrimination tasks to marmosets and rhesus monkeys","Crofts H.S., Muggleton N.G., Bowditch A.P., Pearce P.C., Nutt D.J., Scott E.A.M.",00236772,"Laboratory Animals",33, 3,15,3,1,0,4,0,19
1999,"Alcohol and the brain: Pharmacological insights for psychiatrists","Nutt D.",00071250,"British Journal of Psychiatry",175, ,45,3,7,1,11,0,56
1999,"Extraction of active clonidine-displacing substance from bovine lung and comparison with clonidine-displacing substance extracted from other tissues","Parker C.A., Hudson A.L., Nutt D.J., Dillon M.P., Eglen R.M., Chan S.L.F., Morgan N.G., Crosby J.",00142999,"European Journal of Pharmacology",378, 2,8,0,0,0,0,0,8
1999,"Inhibition of central monoamine oxidase by imidazoline, site-selective ligands","Lalies M.D., Hibell A., Hudson A.L., Nutt D.J.",00778923,"Annals of the New York Academy of Sciences",881, ,27,3,0,1,4,0,31
1999,"Novel selective compounds for the investigation of imidazoline receptors","Hudson A.L., Hutson P., Nutt D.J., Gough R., Tyacke R., Lione L., Lalies M., Lewis J., Husbands S., Knight P., Murray F.",00778923,"Annals of the New York Academy of Sciences",881, ,37,3,3,2,8,0,45
1999,"Comparison of crude methanolic CDS extracts from various tissues","Parker C.A., Hudson A.L., Nutt D.J., Dillon M.P., Eglen R.M., Crosby J.",00778923,"Annals of the New York Academy of Sciences",881, ,3,0,0,0,0,0,3
1999,"Autoradiography of I2 receptors in frog brain","Tyacke R.J., Nutt D.J., Hudson A.L.",00778923,"Annals of the New York Academy of Sciences",881, ,1,0,0,1,1,0,2
1999,"Endogenous indoleamines demonstrate moderate affinity for I2 binding sites","Hudson A.L., Luscombe S., Gough R.E., Nutt D.J., Tyacke R.J.",00778923,"Annals of the New York Academy of Sciences",881, ,4,0,0,1,1,0,5
1999,"The neurobiology of social phobia","Bell C.J., Malizia A.L., Nutt D.J.",09401334,"European Archives of Psychiatry and Clinical Neuroscience",249, ,27,3,1,1,5,0,32
1999,"Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders","Nutt D.J., Forshall S., Bell C., Rich A., Sandford J., Nash J., Argyropoulos S.",0924977X,"European Neuropsychopharmacology",9, 3,60,3,4,1,8,0,68
1999,"The effects of idazoxan on reaction times, eye movements and the mood of healthy volunteers and patients with upper respiratory tract illnesses","Smith A., Sturgess W., Rich N., Brice C., Collison C., Bailey J., Wilson S., Nutt D.J.",02698811,"Journal of Psychopharmacology",13, 2,4,1,0,0,1,0,5
1999,"Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety","Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J., Goldberg D., Magruder K.M., Schulberg H.C., Tylee A., Wittchen H.-U.",01606689,"Journal of Clinical Psychiatry",60, 7,63,1,1,0,2,0,65
1999,"Traumatic brain injury and post-traumatic stress disorder [4] (multiple letters)","McMillan T., Jacobson R.R., Nutt D.",00071250,"British Journal of Psychiatry",174, ,0,0,0,0,0,0,0
1999,"Unconsciousness and post-traumatic stress disorder [2]","O'Brien M., Nutt D., Williams D.D.R., McBride A., Freeman H.L.",00071250,"British Journal of Psychiatry",174, ,3,0,0,0,0,0,3
1999,"Maintenance pharmacotherapy of unipolar depression","Forshall S., Nutt D.J.",09556036,"Psychiatric Bulletin",23, 6,0,0,0,0,0,0,0
1998,"Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex","Thomas D.N., Nutt D.J., Holman R.B.",02698811,"Journal of Psychopharmacology",12, 4,25,2,1,0,3,0,28
1998,"Substance-P antagonists: A new treatment for depression?","Nutt D.",01406736,"Lancet",352, 9141,36,1,2,0,3,0,39
1998,"Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety","Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J., Bobes J., Beidel D.C., Ono Y., Westenberg H.G.M.",01606689,"Journal of Clinical Psychiatry",59, 17,146,2,5,1,8,0,154
1998,"Brain mechanisms of social anxiety disorder","Nutt D.J., Bell C.J., Malizia A.L.",01606689,"Journal of Clinical Psychiatry",59, 17,48,2,1,2,5,0,53
1998,"Potentiation of barbiturate-induced alterations in presynaptic noradrenergic function in rat frontal cortex by imidazol(in)e ?2-adrenoceptor agonists","Dalley J.W., Parker C.A., Wulfert E., Hudson A.L., Nutt D.J.",00071188,"British Journal of Pharmacology",125, 3,13,0,0,0,0,0,13
1998,"'Seeing through a glass darkly': Casting light on imidazoline 'I' sites","Eglen R.M., Hudson A.L., Kendall D.A., Nutt D.J., Morgan N.G., Wilson V.G., Dillon M.P.",01656147,"Trends in Pharmacological Sciences",19, 9,178,4,4,7,15,0,193
1998,"Loss of consciousness and post-traumatic stress disorder. A clue to aetiology and treatment","O'Brien M., Nutt D.",00071250,"British Journal of Psychiatry",173, ,28,0,1,0,1,0,29
1998,"Antidepressants in panic disorder: Clinical and preclinical mechanisms","Nutt D.J.",01606689,"Journal of Clinical Psychiatry",59, 8,22,1,1,0,2,0,24
1998,"Consensus statement on panic disorder from the international consensus group on depression and anxiety","Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J., Baldwin D.S., Den Boer J.A., Kasper S., Shear M.K.",01606689,"Journal of Clinical Psychiatry",59, 8,114,3,3,1,7,0,121
1998,"Potential applications of venlafaxine","Nutt D., Neil Johnson F.",09548602,"Reviews in Contemporary Pharmacotherapy",9, 5,3,0,0,0,0,0,3
1998,"Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder. Preliminary results from a quantitative PET study","Malizia A.L., Cunningham V.J., Bell C.J., Liddle P.F., Jones T., Nutt D.J.",0003990X,"Archives of General Psychiatry",55, 8,180,14,14,5,33,0,213
1998,"Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: A selective ligand for imidazoline I2 receptors","Lione L.A., Nutt D.J., Hudson A.L.",00142999,"European Journal of Pharmacology",353, 1,55,1,4,5,10,0,65
1998,"Serotonin and panic","Bell C.J., Nutt D.J.",00071250,"British Journal of Psychiatry",172, ,58,6,2,1,9,0,67
1998,"Efficacy of mirtazapine in clinically relevant subgroups of depressed patients","Nutt D.J.",10914269,"Depression and Anxiety",7, 1,10,0,1,0,1,0,11
1998,"Pindolol augmentation of sertraline in resistant depression and its effect on sleep","Bell C., Wilson S., Nutt D.J.",02698811,"Journal of Psychopharmacology",12, 1,5,0,0,0,0,0,5
1998,"Integrating the cognitive and physiological aspects of craving","Weinstein A., Feldtkeller B., Malizia A., Wilson S., Bailey J., Nutt D.J.",02698811,"Journal of Psychopharmacology",12, 1,38,3,1,0,4,0,42
1998,"Comorbidity in social anxiety disorder: Impact on disease burden and management: Comments","Ballenger J.C., Westenberg H.G.M., Nutt D.J.",01606689,"Journal of Clinical Psychiatry",59, 17,0,0,0,0,0,0,0
1998,"Social anxiey disorder: Etiology and early clinical presentation: Comments","Ballenger J.C., Nutt D.J., Lecrubier Y., Davidson J.R.T., Westenberg H.G.M.",01606689,"Journal of Clinical Psychiatry",59, 17,0,0,0,0,0,0,0
1998,"Prescriptions, licences and evidence","Healy D., Nutt D.",09556036,"Psychiatric Bulletin",22, 11,9,1,0,1,2,0,11
1998,"Pharmacotherapy of social anxiety disorder: Comments","Westenberg H.G.M., Lecrubier Y., Ballenger J.C., Nutt D.J., Bobes J.",01606689,"Journal of Clinical Psychiatry",59, 17,0,0,0,0,0,0,0
1998,"Psychotherapy in the overall management strategy for social anxiety disorder: Comments","Nutt D.J., Davidson J.R.T., Ono Y., Ballenger J.C., Lecrubier Y., Westenberg H.G.M.",01606689,"Journal of Clinical Psychiatry",59, 17,0,0,0,0,0,0,0
1998,"How is recovery from social anxiety disorder defined?: Comments","Davidson J.R.T., Lecrubier Y., Ballenger J.C., Westenberg H.G.M., Beidel D.C., Ono Y., Nutt D.J.",01606689,"Journal of Clinical Psychiatry",59, 17,0,0,0,0,0,0,0
1998,"Focus on social anxiety disorder: Introduction","Ballenger J.C., Davidson J.R.T., Lecrubier Y., Nutt D.J.",01606689,"Journal of Clinical Psychiatry",59, 17,3,0,0,0,0,0,3
1998,"The nature of social anxiety disorder: Comments","Nutt D.J., Davidson J.R.T., Lecrubier Y., Ballenger J.C., Beidel D.C., Ono Y.",01606689,"Journal of Clinical Psychiatry",59, 17,0,0,0,0,0,0,0
1997,"Child and learning disability psychopharmacology","Adams S., Ashford J., Bailey S., Barton J., Bramble D., Chiswell R., Cook E., Cosgrove F., Daniels S., Dourish C., Flament M., Harrington R., Healy D., Hill J., Hollis C., Kerr M., King B., Klein R., Klein D., Kutcher S., Leber P., Nutt D., Reason R., Remschmidt H., Reynolds A., Riddle M., Robbins T., Sahakian B., Sandberg S., Sharp S., Snape M., Stonier P., Tuinier S., Tyrer S., Van Zwieten-Boot B., Verhoeven W., Weathers J., Wilkinson D.",02698811,"Journal of Psychopharmacology",11, 4,8,0,0,0,0,0,8
1997,"Flumazenil delivery changes in panic disorder at rest","Malizia A.L., Cunningham V.J., Nutt D.J.",10538119,"NeuroImage",5, 4,1,0,0,0,0,0,1
1997,"Anhedonia and chronic mild stress model in depression","Argyropoulos S.V., Nutt D.J.",00333158,"Psychopharmacology",134, 4,7,2,2,0,4,0,11
1997,"Do SSRIs prolong seizure duration during ECT?","Potokar J., Wilson S., Nutt D.J.",13651501,"International Journal of Psychiatry in Clinical Practice",1, 4,3,0,0,0,0,0,3
1997,"Neural correlates of anxiety provocation in Social Phobia","Malizia A.L., Wilson S.J., Bell C.M., Nutt D.J., Grasby P.M.",10538119,"NeuroImage",5, 4,11,0,0,0,0,0,11
1997,"Noradrenaline in depression: half a century of progress.","Nutt D.J.",02698811,"Journal of psychopharmacology (Oxford, England)",11, 4,4,0,0,0,0,0,4
1997,"Flumazenil in alcohol withdrawal: A double-blind placebo-controlled study","Potokar J., Coupland N., Glue P., Groves S., Malizia A., Bailey J., Wilson S., Nutt D.",07350414,"Alcohol and Alcoholism",32, 5,8,1,1,0,2,0,10
1997,"Imagery of craving in opiate addicts undergoing detoxification","Weinstein A., Wilson S., Bailey J., Myles J., Nutt D.",03768716,"Drug and Alcohol Dependence",48, 1,21,1,3,0,4,0,25
1997,"Demonstration of clomipramine and venlafaxine occupation at serotonin reuptake sites in man in vivo","Malizia A.L., Melichar J.M., Brown D.J., Gunn R.N., Reynolds A., Jones T., Nutt D.J.",02698811,"Journal of Psychopharmacology",11, 3,8,0,0,1,1,0,9
1997,"Antisense oligonucleotides in psychopharmacology and behaviour: Promises and pitfalls","Robinson E.S.J., Nutt D.J., Jackson H.C., Hudson A.L.",02698811,"Journal of Psychopharmacology",11, 3,18,0,0,0,0,0,18
1997,"''Tis a wonder it works at all!'","Nutt D.J.",09652140,"Addiction",92, 8,2,0,0,0,0,0,2
1997,"Management of patients with depression associated with anxiety symptoms","Nutt D.",01606689,"Journal of Clinical Psychiatry",58, 8,33,0,0,0,0,0,33
1997,"Adult night terrors and paroxetine [3]","Wilson S.J., Lillywhite A.R., Potokar J.P., Bell C.J., Nutt D.J.",01406736,"Lancet",350, 9072,7,3,1,0,4,0,11
1997,"Noradrenergic mechanisms in the prefrontal cortex","Nutt D.J., Lalies M.D., Lione L.A., Hudson A.L.",02698811,"Journal of Psychopharmacology",11, 2,42,2,0,0,2,0,44
1997,"The neurochemistry of addiction","Nutt D.J.",08856222,"Human Psychopharmacology",12, 2,8,1,0,0,1,0,9
1997,"A pilot controlled study of the effects of flumazenil in posttraumatic stress disorder","Coupland N.J., Lillywhite A., Bell C.E., Potokar J.P., Nutt D.J.",00063223,"Biological Psychiatry",41, 9,15,1,2,0,3,0,18
1997,"Antidepressant drugs and the cardiovascular system: A comparison of tricylics and selective serotonin reuptake inhibitors and their relevance for the treatment of psychiatric patients with cardiovascular problems","Coupland N., Wilson S., Nutt D.",02698811,"Journal of Psychopharmacology",11, 1,22,2,0,0,2,0,24
1997,"Association of short alleles of a VNTR of the serotonin transporter gene with anxiety symptoms in patients presenting after deliberate self harm","Evans J., Battersby S., Ogilvie A.D., Smith C.A.D., Harmar A.J., Nutt D.J., Goodwin G.M.",00283908,"Neuropharmacology",36, 4-5,34,3,1,0,4,0,38
1997,"Moclobemide in social phobia. A double-blind, placebo-controlled clinical study","Burrows G., Evans L., Baumhackl U., Hebenstreit H., Katschnig H., Schony W., Scholz H., Wilmotte J., Campos J., Costa D., Nardi A., Versiani M., Da Silva A., Bowen D.L.R., Bradwejn J., Johnston D., Plamondon J., Stein M., Swinson R., Chneiweiss L., Bellaire W., Osterheider M., Sonntag R., Cookson J., Freeman C., Hirsch S., Mullin J., Murray R., Nutt D., Petursson H., O'Donoghue F., Min J., Allgulander C., Andersch S., Realini R., Siegel J.L., Buller R.",09401334,"European Archives of Psychiatry and Clinical Neuroscience",247, 2,34,0,0,0,0,0,34
1997,"Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects","George D.T., Benkelfat C., Rawlings R.R., Eckardt M.J., Phillips M.J., Nutt D.J., Wynne D., Murphy D.L., Linnoila M.",0002953X,"American Journal of Psychiatry",154, 1,42,0,1,0,1,0,43
1997,"Editorial: Psychopharmacology of the prefrontal cortex","Nutt D.J.",02698811,"Journal of Psychopharmacology",11, 2,0,0,0,0,0,0,0
1997,"Promises and pitfalls. Commentary on Antelman et al., 'Time-dependent sensitization (TDS)- Possible implications for clinical psychopharmacology'","Nutt D.",09558810,"Behavioural Pharmacology",8, 6-7,0,0,0,0,0,0,0
1997,"5-HT3 receptors, nausea, and serotonin reuptake inhibition [20]","Coupland N.J., Bailey J.E., Potokar J.P., Nutt D.J.",02710749,"Journal of Clinical Psychopharmacology",17, 2,4,0,0,0,0,0,4
1997,"Case Histroy 3","Nutt D.J., Den Boer J.A.",08856222,"Human Psychopharmacology",12, 1,0,0,0,0,0,0,0
1997,"Analysis of dynamic radioligand displacement or 'activation' studies","Friston K.J., Malizia A.L., Wilson S., Cunningham V.J., Jones T., Nutt D.J.",0271678X,"Journal of Cerebral Blood Flow and Metabolism",17, 1,17,1,1,1,3,0,20
1997,"Organization of opioid receptors in human brain and drug interactions studied by PET and SPECT imaging: Implications for treatment strategies for opiate addiction","Melichar J.K., Malizia A.L., Nutt D.J.",10445765,"Seminars in the Neurosciences",9, 3-4,4,0,1,0,1,0,5
1997,"Satellite Symposium to the British Association for Psychopharmacology, 13 July 1997: Noradrenaline in depression: Half a century of progress","Nutt D.J.",02698811,"Journal of Psychopharmacology",11, 4,4,0,0,0,0,0,4
1997,"Identification of ligands selective for central I2-imidazoline binding sites","Hudson A.L., Chapleo C.B., Lewis J.W., Husbands S., Grivas K., Mallard N.J., Nutt D.J.",01970186,"Neurochemistry International",30, 1,17,2,1,5,8,0,25
1997,"Receptor pharmacology of buprenorphine","Nutt D.J.",01433083,"Research and Clinical Forums",19, 2,12,1,0,0,1,0,13
1997,"Mirtazapine: Pharmacology in relation to adverse effects","Nutt D.",00651591,"Acta Psychiatrica Scandinavica, Supplement",96, 391,58,2,3,1,6,0,64
1997,"The feasibility of abrupt methadone-buprenorphine transfer in British opiate addicts in an outpatient setting","Law F.D., Bailey J.E., Allen D.S., Melichar J.K., Myles J.S., Mitcheson M.C., Lewis J.W., Nutt D.J.",13556215,"Addiction Biology",2, 2,21,1,0,1,2,0,23
1996,"Evaluation in rat of RS-79948-197 as a potential PET ligand for central ?2-adrenoceptors","Hume S.P., Ashworth S., Lammertsma A.A., Opacka-Juffry J., Law M.P., McCarron J.A., Clark R.D., Nutt D.J., Pike V.W.",00142999,"European Journal of Pharmacology",317, 1,22,0,0,1,1,0,23
1996,"Discriminative stimulus produced by the imidazoline I2 site ligand, 2-BFI","Jordan S., Jackson H.C., Nutt D.J., Handley S.L.",02698811,"Journal of Psychopharmacology",10, 4,5,0,0,0,0,0,5
1996,"Role of GABA in memory and anxiety","Kalueff A., Nutt D.J.",10914269,"Depression and Anxiety",4, 3,33,3,10,0,13,0,46
1996,"Cognitive processing in post-traumatic stress disorder","Weinstein A.M., Neal L., Lillywhite A., Potokar J., Nutt D.J.",10709797,"Anxiety",2, 3,5,0,0,0,0,0,5
1996,"Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: Direct measurement of drug occupancy and effects on the human brain in vivo","Malizia A.L., Gunn R.N., Wilson S.J., Waters S.H., Bloomfield P.M., Cunningham V.J., Nutt D.J.",00283908,"Neuropharmacology",35, 9-10,25,2,0,1,3,0,28
1996,"The psychopharmacology of anxiety","Nutt D.J.",00071064,"British Journal of Hospital Medicine",55, 4,8,0,1,0,1,0,9
1996,"Focusing on serotonin for the action of drugs effective in mood disorders: Pre-synaptic versus postsynaptic mechanisms","Nutt D.J.",0924977X,"European Neuropsychopharmacology",6, 1,0,0,0,0,0,0,0
1996,"?2-Adrenoceptors and depression","Nutt D.J., Pinder R.M.",02698811,"Journal of Psychopharmacology",10, 3,17,1,1,1,3,0,20
1996,"? 2-Adrenoceptors in panic and anxiety disorders","Coupland N.J., Wilson S.J., Nutt D.J.",02698811,"Journal of Psychopharmacology",10, 3,4,0,0,0,0,0,4
1996,"Moclobemide in the treatment of social phobia","Nutt D., Montgomery S.A.",02681315,"International Clinical Psychopharmacology",11, 3,22,1,0,0,1,0,23
1996,"The biological, social and clinical bases of drug addiction: Commentary and debate","Altman J., Everitt B.J., Glautier S., Markou A., Nutt D., Oretti R., Phillips G.D., Robbins T.W., Reynolds J.",00333158,"Psychopharmacology",125, 4,172,3,4,1,8,0,180
1996,"Sedative antidepressants impair visual detection mechanisms in humans","Weinstein A., Wilson S., Bailey J., Nutt D.",02698811,"Journal of Psychopharmacology",10, 2,7,0,0,0,0,0,7
1996,"[3H]2-(2-benzofuranyl)-2-imidazoline: A new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors","Lione L.A., Nutt D.J., Hudson A.L.",00142999,"European Journal of Pharmacology",304, 1-3,37,0,1,3,4,0,41
1996,"Imidazoline binding sites in Huntington's and Parkinson's disease putamen","Reynolds G.P., Boulton R.M., Pearson S.J., Hudson A.L., Nutt D.J.",00142999,"European Journal of Pharmacology",301, 1-3,24,1,1,3,5,0,29
1996,"Thyrotropin-releasing hormone: A potential comparator for the panicogenic effects of pentagastrin and CCK? [1]","Coupland N., Malizia A., Bailey J., Nutt D.",00063223,"Biological Psychiatry",39, 6,0,2,0,0,2,0,2
1996,"Noradrenaline and attention lapses.","Smith A., Nutt D.",00280836,"Nature",380, 6572,69,3,4,2,9,0,78
1996,"ECNP position paper on social phobia. Proceedings from an ECNP workshop in Jerusalem, October 1994","Montgomery S.A., Cameron A., Cassano G., Costa e Silva J., Den Boer J.A., Freeman C., Von Knorring L., Loo H., Nutt D., Rosenberg R., Bakish D., Buller R., Gjerris A., Katschnig H., Lecrubier Y., Lepine J.-P., Mauri M., Sartorius N.",0924977X,"European Neuropsychopharmacology",6, 1,3,0,0,0,0,0,3
1996,"TNF? mimics the endocrine but not the thermoregulatory responses of bacterial lipopolysaccharide (LPS): Correlation with FOS-expression in the brain","Tolchard S., Hare A.S., Nutt D.J., Clarke G.",00283908,"Neuropharmacology",35, 3,13,0,0,0,0,0,13
1996,"Estimating the synaptic concentration of norepinephrine in dentate gyrus which produces ?-receptor mediated long-lasting potentiation in vivo using microdialysis and intracerebroventricular norepinephrine","Harley C.W., Lalies M.D., Nutt D.J.",00068993,"Brain Research",710, 1-2,15,1,2,1,4,0,19
1996,"Addiction: Brain mechanisms and their treatment implications","Nutt D.J.",01406736,"Lancet",347, 8993,89,5,2,0,7,0,96
1996,"Early action of nefazodone in anxiety associated with depression","Nutt D.",02698811,"Journal of Psychopharmacology",10, 1,10,0,0,0,0,0,10
1996,"Psychopharmacology","Potokar J., Nutt D.",09517367,"Current Opinion in Psychiatry",9, 1,2,0,0,0,0,0,2
1995,"A new human (psycho)pharmacology tool: The multiple organs coincidences counter (MOCC)","Malizia A., Forse G., Haida A., Gunn R., Melichar J., Poole K., Bateman D., Fahy D., Schnorr L., Brown D., Rhodes C., Nutt D.J., Jones T.",02698811,"Journal of Psychopharmacology",9, 4,10,1,0,0,1,0,11
1995,"Psychopharmacological imaging","Nutt D.J.",02698811,"Journal of Psychopharmacology",9, 4,0,0,0,0,0,0,0
1995,"Functional studies of specific imidazoline-2 receptor ligands","Nutt D.J., Lione L., Mallard N., Pratt J., French N., Handley S., Hudson A., Husbands S., Jackson H., Jordan S., Lalies M.D., Lewis J.",00778923,"Annals of the New York Academy of Sciences",763, ,61,2,2,6,10,0,71
1995,"Venlafaxine: The yin and yang of antidepressants?","Nutt D.J.",02698811,"Journal of Psychopharmacology",9, 3,4,0,0,0,0,0,4
1995,"The cardiovascular and subjective effects of thyrotropin releasing hormone (TRH) and a stable analogue, dimethyl proline-TRH, in healthy volunteers","Coupland N.J., Bailey J.E., Glue P., Nutt D.J.",03065251,"British Journal of Clinical Pharmacology",40, 3,1,0,0,0,0,0,1
1995,"The anxiety factor in depression","Nutt D.",02698811,"Journal of Psychopharmacology",9, 2,8,0,0,0,0,0,8
1995,"The effects of clonidine on cardiovascular responses to standing in healthy volunteers","Coupland N.J., Bailey J.E., Wilson S.J., Horvath R., Nutt D.",09599851,"Clinical Autonomic Research",5, 3,13,0,1,1,2,0,15
1995,"Successful treatment of tardive oculogyric spasms with vitamin E [2]","Coupland N., Nutt D.",02710749,"Journal of Clinical Psychopharmacology",15, 4,2,0,0,0,0,0,2
1995,"Psychopharmacology of benzodiazepines - An update","Malizia A.L., Nutt D.J.",08856222,"Human Psychopharmacology",10, 1,4,1,0,0,1,0,5
1995,"The 5-HT3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man","Bailey J.E., Potokar J., Coupland N., Nutt D.J.",02698811,"Journal of Psychopharmacology",9, 2,32,0,0,0,0,0,32
1995,"A cognitive dysfunction in anxiety and its amelioration by effective treatment with SSRIs","Weinstein A.M., Nutt D.J.",02698811,"Journal of Psychopharmacology",9, 2,8,0,0,1,1,0,9
1995,"Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism","George D.T., Nutt D.J., Rawlings R.R., Phillips M.J.M., Eckardt M.J., Potter W.Z., Linnoila M.",00063223,"Biological Psychiatry",37, 2,20,0,0,0,0,0,20
1995,"Idazoxan-induced reductions in cortical glucose use are accompanied by an increase in noradrenaline release: Complementary [14C]-2-deoxyglucose and microdialysis studies","French N., Lalies M.D., Nutt D.J., Pratt J.A.",00283908,"Neuropharmacology",34, 6,12,0,0,0,0,0,12
1995,"Effect of chloride or glucose on the incidence of lactate-induced panic attacks","George D.T., Lindquist T., Nutt D.J., Ragan P.W., Alim T., McFarlane V., Leviss J., Eckardt M.J., Linnoila M.",0002953X,"American Journal of Psychiatry",152, 5,5,1,0,0,1,0,6
1995,"Erratum: Editorial: Venlaxine: The yin and yang of antidepressants (Journal of Psychopharmacology (1995) 9 (205))","Nutt D.J.",02698811,"Journal of Psychopharmacology",9, 4,0,0,0,0,0,0,0
1995,"The relationship between benzodiazepine receptor sensitivity and neuroticism","Glue P., Wilson S., Coupland N., Ball D., Nutt D.",08876185,"Journal of Anxiety Disorders",9, 1,13,0,0,1,1,0,14
1995,"A comparison of the effects of phenelzine treatment with moclobemide treatment on cardiovascular reflexes","Coupland N.J., Wilson S.J., Potokar J.P., Bell C.E., Bailey J.E., Nutt D.J.",02681315,"International Clinical Psychopharmacology",10, 4,9,0,1,0,1,0,10
1995,"The effects of flumazenil in neuropsychiatric disorders","Malizia A.L., Nutt D.J.",03625664,"Clinical Neuropharmacology",18, 3,14,0,0,0,0,0,14
1995,"Benzodiazepine receptor function in anxiety disorders.","Malizia A.L., Coupland N.J., Nutt D.J.",00652229,"Advances in biochemical psychopharmacology",48, ,18,0,0,0,0,0,18
1995,"Use of selective serotonin reuptake inhibitors and other serotonergic drugs in the biological dissection of affective disorders","Nutt D.J., Wilson S.J., Coupland N.J.",02681315,"International Clinical Psychopharmacology",9, 4,5,0,0,0,0,0,5
1995,"Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites","Carpene C., Collon P., Remaury A., Cordi A., Hudson A., Nutt D., Lafontan D.",00223565,"Journal of Pharmacology and Experimental Therapeutics",272, 2,81,3,2,2,7,0,88
1994,"Putting the 'A' in atypical: Does ?2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?","Nutt D.J.",02698811,"Journal of Psychopharmacology",8, 4,42,2,1,0,3,0,45
1994,"A pharmacodynamic study of the ? 2-adrenergic receptor antagonist ethoxyidazoxan in healthy volunteers","Coupland N.J., Bailey J.E., Wilson S.J., Potter W.Z., Nutt D.J.",00099236,"Clinical Pharmacology and Therapeutics",56, 4,14,0,0,0,0,0,14
1994,"Long-term effects of SSRIs and TCAs on sleep","Wilson S.J., Bell C., Coupland N.J., Nutt D.J.",0924977X,"European Neuropsychopharmacology",4, 3,1,0,0,0,0,0,1
1994,"A comparison of the effects of sertraline and clomipramine on postural blood pressure changes and heart rate and blood pressure variability","Coupland N.J., Wilson S.J., Bailey J.E., Potokar J., Nutt D.J.",0924977X,"European Neuropsychopharmacology",4, 3,4,0,0,0,0,0,4
1994,"An investigation of effects of fluvoxamine and dothiepin on sleep and daytime sleepiness in normal volunteers","Wilson S.J., Bailey J.E., Ashford J.J., Alford C.J., Coupland N.J., Nutt D.J.",0924977X,"European Neuropsychopharmacology",4, 3,0,0,0,0,0,0,0
1994,"Regional specific changes in extracellular noradrenaline following chronic idazoxan as revealed by in vivo microdialysis","Thomas D.N., Nutt D., Holman R.B.",00142999,"European Journal of Pharmacology",261, 1-2,11,0,0,0,0,0,11
1994,"Psychotropic drug development - Social, scientific and economic issues BAP Autumn Meeting, November 1993","Nutt D.",02698811,"Journal of Psychopharmacology",8, 2,0,0,0,0,0,0,0
1994,"Selective serotonin reuptake inhibitors: Meta-analysis of discontinuation rates","Montgomery S.A., Henry J., McDonald G., Dinan T., Lader M., Hindmarch I., Clare A., Nutt D.",02681315,"International Clinical Psychopharmacology",9, 1,217,1,4,0,5,0,222
1994,"New approaches to drug dependency","Nutt D.",02698811,"Journal of Psychopharmacology",8, 1,0,0,0,0,0,0,0
1994,"Neuroendocrine and clinical effects of electroconvulsive therapy and their relationship to treatment outcome","Smith J., Williams K., Birkett S., Nicholson H., Glue P., Nutt D.J.",00332917,"Psychological Medicine",24, 3,8,1,1,0,2,0,10
1994,"Alcohol: The drug","Nutt D.J., Peters T.J.",00071420,"British Medical Bulletin",50, 1,21,1,1,0,2,0,23
1994,"Erratum: Selective serotonin reuptake inhibitors: Meta analysis of discontinuation rates ( International Clinical Psychopharmacology Volume 9, Number 1, Spring 1994: page 50","Montgomery S.A., Henry J., McDonald G., Dinan T., Lader M., Hindmarch I., Clare A., Nutt D.",02681315,"International Clinical Psychopharmacology",9, 4,0,0,0,0,0,0,0
1994,"Successful treatment of night terrors and somnambulism with paroxetine","Lillywhite A.R., Wilson S.J., Nutt D.J.",00071250,"British Journal of Psychiatry",164, ,22,5,0,0,5,0,27
1994,"Successful treatment of fluvoxamine-induced anorgasmia by cyproheptadine","Arnott S., Nutt D.",00071250,"British Journal of Psychiatry",164, ,42,0,0,0,0,0,42
1993,"Antidepressants and mania: To stop or not to stop?","Allen D., Horvath R., Nutt D.",08856222,"Human Psychopharmacology",8, 5,5,0,0,0,0,0,5
1993,"Flumazenil in alcohol withdrawal.","Nutt D., Glue P., Wilson S., Groves S., Coupland N., Bailey J.",13586173,"Alcohol and alcoholism (Oxford, Oxfordshire). Supplement.",2, ,10,1,0,0,1,0,11
1993,"Beat to beat monitoring of orthostatic hypotension - A comparison of phenelzine with moclobemide","Coupland N.J., Wilson S.J., Bailey J.E., Potokar J., Nutt D.J.",0924977X,"European Neuropsychopharmacology",3, 3,0,0,0,0,0,0,0
1993,"Effects of fluvoxamine and clomipramine treatment on beat-by-beat changes in blood pressure during standing","Wilson S.J., Lillywhite A.R., Coupland N.J., Potokar J., Bailey J.E., Nutt D.J.",0924977X,"European Neuropsychopharmacology",3, 3,1,0,0,0,0,0,1
1993,"Benzodiazepine receptors and panic","Nutt D., Coupland N., Potokar J., Lillywhite A., Wilson S., Bailey J.",0924977X,"European Neuropsychopharmacology",3, 3,2,0,0,0,0,0,2
1993,"Co-existence of panic disorder and sleep paralysis","Allen D., Nutt D.",02698811,"Journal of Psychopharmacology",7, 3,1,0,0,0,0,0,1
1993,"The approach to new anxiolytics","Nutt D.J.",00223573,"Journal of Pharmacy and Pharmacology",45, 1,1,0,0,0,0,0,1
1993,"Monoamine oxidase inhibitors: In from the cold?","Nutt D.",02698811,"Journal of Psychopharmacology",7, 1,0,0,0,0,0,0,0
1993,"Central ?-2 adrenoceptors are responsible for a clonidine-induced cue in a rat drug discrimination paradigm","Jordan S., Jackson H.C., Nutt D.J., Handley S.L.",00333158,"Psychopharmacology",110, 1-2,5,0,0,0,0,0,5
1993,"Saccadic eye movement parameters in normal subjects","Wilson S.J., Glue P., Ball D., Nutt D.J.",00134649,"Electroencephalography and Clinical Neurophysiology",86, 1,25,2,2,0,4,0,29
1993,"A single preexposure produces sensitization to the locomotor effects of cocaine in mice","Jackson H.C., Nutt D.J.",00913057,"Pharmacology Biochemistry and Behavior",45, 3,33,2,5,0,7,0,40
1993,"Erratum: Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites - current status (Nucl. Med. Biol. 20, 503-525)","Pile V.W., Halldin C., Crouzel C., Barre L., Nutt D.J., Osman S., Shah F., Turton D.R., Waters S.L.",08832897,"Nuclear Medicine and Biology",20, 6,0,0,0,0,0,0,0
1993,"Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites - Current status","Pike V.W., Halldin C., Crouzel C., Barre L., Nutt D.J., Osman S., Shah F., Turton D.R., Waters S.L.",08832897,"Nuclear Medicine and Biology",20, 4,58,4,3,1,8,0,66
1993,"Neurochemistry of drugs other than alcohol","Nutt D.J.",09517367,"Current Opinion in Psychiatry",6, 3,1,0,0,0,0,0,1
1993,"Investigation of the involvement of opioid receptors in the action of anticonvulsants","Jackson H.C., Nutt D.J.",00333158,"Psychopharmacology",111, 4,8,0,0,0,0,0,8
1993,"State of the Art. The psychopharmacology of social communication and its disorders","Nutt D.J.",02698811,"Journal of Psychopharmacology",7, 2,0,0,0,0,0,0,0
1993,"Buprenorphine-cocaine interactions in mice: Effect on locomotor activity and hole-dipping behaviour","Jackson H.C., Griffin I.J., Nutt D.J.",00223573,"Journal of Pharmacy and Pharmacology",45, 7,8,0,0,1,1,0,9
1992,"Psychopharmacology of schizophrenia. Badgastein, Austria, 26 January-1 February 1992","Nutt D.",02698811,"Journal of Psychopharmacology",6, 4,0,0,0,0,0,0,0
1992,"Strain differences in sensitivity to the hypothermic effects of benzodiazepine receptor ligands in mice","Jackson H.C., Nutt D.J.",00333158,"Psychopharmacology",109, 3,5,0,0,0,0,0,5
1992,"Are 5-HT receptors or ?-adrenoceptors involved in idazoxan-induced food and water intake?","Jackson H.C., Nutt D.J.",00283908,"Neuropharmacology",31, 11,8,0,0,0,0,0,8
1992,"Quantification of in vivo binding of [3H]RX 821002 in rat brain: Evaluation as a radioligand for central ?2-adrenoceptors","Hume S.P., Lammertsma A.A., Opacka-Juffry J., Ahier R.G., Myers R., Cremer J.E., Hudson A.L., Nutt D.J., Pike V.W.",08832897,"International Journal of Radiation Applications and Instrumentation.",19, 8,0,0,0,0,0,0,0
1992,"Effects of benzodiazepine receptor inverse agonists on locomotor activity and exploration in mice","Jackson H.C., Nutt D.J.",00142999,"European Journal of Pharmacology",221, 2-3,15,1,0,1,2,0,17
1992,"Alpha-2-adrenoceptor control of cortisol and ACTH in normal volunteers: Preliminary open trial of the effects of acute and chronic idazoxan","Glue P., Wilson S., Campling G.M., Knightly M., Franklin M., Cowen P.J., Nutt D.J.",03064530,"Psychoneuroendocrinology",17, 2-3,4,0,0,0,0,0,4
1992,"Quantification of in vivo binding of [3H]RX 821002 in rat brain: Evaluation as a radioligand for central ?2-adrenoceptors","Hume S.P., Lammertsma A.A., Opacka-Juffry J., Ahier R.G., Myers R., Cremer J.E., Hudson A.L., Nutt D.J., Pike V.W.",08832897,"Nuclear Medicine and Biology",19, 8,17,1,1,0,2,0,19
1992,"Challenge tests: Assessment of the noradrenergic and GABA systems in depression and anxiety disorders","Coupland N., Glue P., Nutt D.J.",00982997,"Molecular Aspects of Medicine",13, 3,13,0,1,0,1,0,14
1992,"Effect of fluvoxamine and non-selective antidepressants on cardiovascular reflexes","Wilson S., Coupland N., Glue P., Nutt D.J.",0924977X,"European Neuropsychopharmacology",2, 3,0,0,0,0,0,0,0
1992,"Endogenous opioids may be involved in idazoxan-induced food intake","Jackson H.C., Griffin I.J., Nutt D.J.",00283908,"Neuropharmacology",31, 8,7,0,0,0,0,0,7
1992,"Effect of the cyclopyrrolones suriclone and RP 59037 on body temperature in mice","Jackson H.C., Ramsay E., Nutt D.J.",00142999,"European Journal of Pharmacology",216, 1,5,0,0,0,0,0,5
1992,"[3H]-RX821002: A highly selective ligand for the identification of ?2-adrenoceptors in the rat brain","Hudson A.L., Mallard N.J., Tyacke R., Nutt D.J.",09595244,"Molecular Neuropharmacology",1, 4,47,0,0,1,1,0,48
1992,"Flumazenil and saccadic eye movements in patients with panic disorder and normal controls","Wilson S., Glue P., Nutt D.",08856222,"Human Psychopharmacology",7, 1,3,0,1,0,1,0,4
1992,"Black bile and noradrenaline: Alternative views on the pathogenesis of depression. The psychopharmacology of depression - Kensington Town Hall, London, November 21-22, 1991","Nutt D., Montgomery S.",02698811,"Journal of Psychopharmacology",6, 3,0,0,0,0,0,0,0
1992,"?2-adrenoceptor antagonists block the stimulant effects of cocaine in mice","Jackson H.C., Griffin I.J., Nutt D.J.",00243205,"Life Sciences",50, 19,6,0,0,0,0,0,6
1992,"Panic attacks. An neurochemical overview of models and mechanisms","Nutt D., Lawson C.",00071250,"British Journal of Psychiatry",160, ,95,1,0,2,3,0,98
1992,"Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements","Glue P., Bailey J., Wilson S., Hudson A., Nutt D.J.",00243205,"Life Sciences",50, 6,12,0,0,0,0,0,12
1992,"The effects of idazoxan and other ? 2-adrenoceptor antagonists on urine output in the rat","Jackson H.C., Griffin I.J., Birkett S.D., Nutt D.J.",00071188,"British Journal of Pharmacology",106, 2,0,0,0,0,0,0,0
1992,"Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex","Thomas D.N., Nutt D.J., Holman R.B.",00071188,"British Journal of Pharmacology",106, 2,30,1,1,0,2,0,32
1992,"Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain","Mallard N.J., Hudson A.L., Nutt D.J.",00071188,"British Journal of Pharmacology",106, 4,80,1,0,1,2,0,82
1992,"The effects and after effects of the ? 2-adrenoceptor antagonist idazoxan on mood, memory and attention in normal volunteers","Smith A.P., Wilson S.J., Glue P., Nutt D.J.",02698811,"Journal of Psychopharmacology",6, 3,22,2,0,0,2,0,24
1992,"The effects of electroconvulsive therapy on plasma insulin and glucose in depression","Williams K., Smith J., Glue P., Nutt D.",00071250,"British Journal of Psychiatry",161, ,5,0,1,0,1,0,6
1992,"Investigations on the ""set-point"" theory of benzodiazepine receptor function.","Nutt D.J., Smith C.F., Bennett R., Jackson H.C.",00652229,"Advances in biochemical psychopharmacology",47, ,12,0,0,0,0,0,12
1992,"Clinical correlates of benzodiazepine receptor function.","Nutt D.J., Glue P., Wilson S., Coupland N., Lillywhite A.",03625664,"Clinical Neuropharmacology",15, ,1,0,0,0,0,0,1
1992,"Chronic use of alcohol and/or benzodiazepines may account for evidence of altered benzodiazepine receptor sensitivity in panic disorder","Stewart S.H., Pihl R.O., Padjen A.L., Nutt D.J., Glue P., Wilson S., Roy-Byrne P.P., Cowley D.S., Hommer D.W.",0003990X,"Archives of General Psychiatry",49, 4,11,0,0,0,0,0,11
1992,"Attenuation of the behavioural effects of ethanol in mice by des-enkephalin-gamma-endorphin (ORG 5878)","Jackson H.C., Ramsay E., Nutt D.J.",07350414,"Alcohol and Alcoholism",27, 4,1,0,0,0,0,0,1
1992,"Pharmacoendocrine studies in anxiety.","Nutt D.J.",03625664,"Clinical Neuropharmacology",15, ,0,0,0,0,0,0,0
1991,"Acute and chronic idazoxan in normal volunteers: Biochemical, physiological and psychological effects","Glue P., Wilson S., Lawson C., Campling G.M., Franklin M., Cowen P.J., Nutt D.J.",02698811,"Journal of Psychopharmacology",5, 4,5,0,0,0,0,0,5
1991,"State of the Art : The three S's - Subtyping subunits in sardinia GABAergic synaptic transmission, molecular, pharmacological and clinical aspects","Nutt D.J.",02698811,"Journal of Psychopharmacology",5, 4,0,0,0,0,0,0,0
1991,"Noradrenaline revisited","Nutt D.",02698811,"Journal of Psychopharmacology",5, 4,0,0,0,0,0,0,0
1991,"Anticonvulsant activity of the imidazoline 6,7-benzoidazoxan","Jackson H.C., Ripley T.L., Dickinson S.L., Nutt D.J.",09201211,"Epilepsy Research",9, 2,2,0,0,0,0,0,2
1991,"Effects of chronic ?2-adrenoceptor blockade on platelet and lymphocyte adrenoceptor binding in normal volunteers","Glue P., Payvandi N., Kay G., Elliott J.M., Nutt D.J.",00243205,"Life Sciences",49, 8,2,0,0,0,0,0,2
1991,"Inhibition of baclofen-induced hypothermia in mice by the novel GABA(B) antagonist CGP 35348","Jackson H.C., Nutt D.J.",00283908,"Neuropharmacology",30, 5,12,0,0,0,0,0,12
1991,"Effect of benzodiazepine and ?-carboline antagonists and partial agonists on loprazolam- and ZK 93423-induced hypothermia","Jackson H.C., Nutt D.J.",00142999,"European Journal of Pharmacology",193, 2,2,0,0,0,0,0,2
1991,"The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: Results of a placebo-controlled study","Hart Y.M., Meinardi H., Sander J.W.A.S., Nutt D.J., Shorvon S.D.",00223050,"Journal of Neurology Neurosurgery and Psychiatry",54, 4,10,0,0,0,0,0,10
1991,"The effects of idazoxan and other ?2-adrenoceptor antagonists on food and water intake in the rat","Jackson H.C., Griffin I.J., Nutt D.J.",00071188,"British Journal of Pharmacology",104, 1,29,0,1,0,1,0,30
1991,"Benzodiazepine receptor sensitivity in panic disorder","Glue P., Nutt D.J.",01406736,"Lancet",337, 8740,2,0,0,0,0,0,2
1991,"Differential effects of selective ?-, ?- and ?-opioid antagonists on electroshock seizure threshold in mice","Jackson H.C., Nutt D.J.",00333158,"Psychopharmacology",103, 3,9,0,0,0,0,0,9
1991,"Disturbances of hypothalamic-pituitary-adrenal axis functioning during ethanol withdrawal in six men","Adinoff B., Risher-Flowers D., De Jong J., Ravitz B., Bone G.H.A., Nutt D.J., Roehrich L., Martin P.R., Linnoila M.",0002953X,"American Journal of Psychiatry",148, 8,70,5,6,0,11,0,81
1991,"Irritability in panic disorder: Effects of imipramine treatment","Nutt D.J., Glue P.",08856222,"Human Psychopharmacology",6, 1,0,0,0,0,0,0,0
1991,"The effects of the ? 2-adrenoceptor antagonist idazoxan on sleep in normal volunteers","Wilson S.J., Glue P., Nutt D.J.",02698811,"Journal of Psychopharmacology",5, 2,3,0,0,0,0,0,3
1991,"Exploring the pharmacology of the pro-convulsant effects of ?2-adrenoceptor antagonists in mice","Jackson H.C., Dickinson S.L., Nutt D.J.",00333158,"Psychopharmacology",105, 4,17,1,0,1,2,0,19
1991,"Buprenorphine and schizophrenia","Groves S., Nutt D.",08856222,"Human Psychopharmacology",6, 1,4,0,1,0,1,0,5
1991,"The NEW Journal of Psychopharmacology","Nutt D., Lister R.",02698811,"Journal of Psychopharmacology",5, 1,0,0,0,0,0,0,0
1991,"Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil","Ball D.M., Glue P., Wilson S., Nutt D.J.",00333158,"Psychopharmacology",105, 3,37,1,1,0,2,0,39
1991,"Do opioid, ?2-adrenoreceptors, or benzodiazepine receptors mediate ECS-induced hypothermia in mice?","Jackson H.C., Weinberger P.J., Nutt D.J.",07498055,"Convulsive Therapy",7, 1,0,0,0,0,0,0,0
1991,"Imipramine in panic disorder. 2. Effects on ?2-adrenoceptor function","Nutt D.J., Glue P.",02698811,"Journal of Psychopharmacology",5, 2,2,1,1,0,2,0,4
1991,"Investigation of the different types of opioid receptor involved in electroconvulsive shock-induced antinociception and catalepsy in the rat","Jackson H.C., Nutt D.J.",00223573,"Journal of Pharmacy and Pharmacology",43, 9,4,0,0,0,0,0,4
1991,"Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients [3]","Benkelfat C., Murphy D.L., Hill J.L., George D.T., Nutt D., Linnoila M.",0003990X,"Archives of General Psychiatry",48, 4,53,0,0,0,0,0,53
1991,"Imipramine in panic disorder. 1. Clinical response and pharmacological changes","Nutt D.J., Glue P.",02698811,"Journal of Psychopharmacology",5, 1,3,0,0,0,0,0,3
1991,"Pharmacology of saccadic eye movements in man. 2. Effects of the ?2-adrenoceptor ligands idazoxan and clonidine","Glue P., White E., Wilson S., Ball D.M., Nutt D.J.",00333158,"Psychopharmacology",105, 3,15,0,1,1,2,0,17
1991,"Comparison of the effects of benzodiazepine and ?-carboline inverse agonists on body temperature in mice","Jackson H.C., Nutt D.J.",00142999,"European Journal of Pharmacology",205, 2,3,1,1,0,2,0,5
1991,"An unsquared circle: Biological council symposium on experimental approaches to anxiety and depression","Nutt D.J.",02698811,"Journal of Psychopharmacology",5, 3,0,0,0,0,0,0,0
1991,"Flumazenil as an anti-epileptic agent [35]","Hart Y.M., Sander J.W.A.S., Meinardi H., Nutt D.J., Shorvon S.D.",01406736,"Lancet",337, 8743,4,0,0,0,0,0,4
1991,"Smaller fleas ad infinitum: Pharmacological subtypes of anxiety?","Nutt D.J.",02698811,"Journal of Psychopharmacology",5, 2,0,0,0,0,0,0,0
1990,"British Association for Psychopharmacology (BAP)","Nutt D.J., Lister R.",02698811,"Journal of Psychopharmacology",4, 4,0,0,0,0,0,0,0
1990,"An end to the 'age of innocence'! New complexities of anxiety","Nutt D.J.",02698811,"Journal of Psychopharmacology",4, 4,1,0,0,0,0,0,1
1990,"Neuropharmacological and clinical aspects of alcohol withdrawal","Nutt D.J., Glue P.",07853890,"Annals of Medicine",22, 4,12,0,0,0,0,0,12
1990,"Body temperature discriminates between full and partial benzodiazepine receptor agonists","Jackson H.C., Nutt D.J.",00142999,"European Journal of Pharmacology",185, 2-3,6,1,0,0,1,0,7
1990,"Noradrenergic mechanisms appear not to be involved in cocaine-induced seizures and lethality","Jackson H.C., Ball D.M., Nutt D.J.",00243205,"Life Sciences",47, 4,7,0,0,0,0,0,7
1990,"The pharmacology of human anxiety","Nutt D.J.",01637258,"Pharmacology and Therapeutics",47, 2,44,0,1,0,1,0,45
1990,"Lactate-induced electrolyte changes in the cerebrospinal fluid of rabbits","George D.T., Glue P., Bacher J.D., Waxman R.P., Nutt D.J.",00063223,"Biological Psychiatry",27, 1,1,0,0,0,0,0,1
1990,"Regional neurotransmitter responses after acute and chronic electroconvulsive shock","Glue P., Costello M.J., Pert A., Mele A., Nutt D.J.",00333158,"Psychopharmacology",100, 1,29,3,1,0,4,0,33
1990,"Carbamazepine retards the development of cocaine-kindled seizures but not sensitization to cocaine-induced hyperactivity","Weiss S.R.B., Post R.M., Costello M., Nutt D.J., Tandeciarz S.",0893133X,"Neuropsychopharmacology",3, 4,11,1,0,0,1,0,12
1990,"Oxytocin and vasopressin responses to ECT","Smith J.E., Williams K., Burkett S., Nicholson H., Glue P., Nutt D.J.",01651781,"Psychiatry Research",32, 2,1,1,1,0,2,0,3
1990,"Specific anatomy, non-specific drugs: The present state of schizophrenia. 5th Biennial Winter Workshop on Schizophrenia","Nutt D.",02698811,"Journal of Psychopharmacology",4, 3,3,0,0,0,0,0,3
1990,"A cerebrospinal fluid study of the pathophysiology of panic disorder associated with alcoholism","George D.T., Adinoff B., Ravitz B., Nutt D.J., De Jong Berrettini J.W., Mefford I.N., Costa E., Linnoila M.",0001690X,"Acta Psychiatrica Scandinavica",82, 1,6,0,2,0,2,0,8
1990,"Diazepam and Ro 15-1788 increase absence epilepsy in WAG/Rij rats chronically exposed to diazepam","Peeters B.W.M.M., Van Rijn C.M., Nutt D.J., Titulaer M.N.G., Vossen J.M.H., Coenen A.M.L.",00142999,"European Journal of Pharmacology",178, 1,5,1,0,0,1,0,6
1990,"From CRH to cognitions: BAP symposium on the neurobiology of stress","Nutt D.",02698811,"Journal of Psychopharmacology",4, 3,0,0,0,0,0,0,0
1990,"Lithium treatment effect on serotonin function (I)","Glue P., Nutt D.J.",0003990X,"Archives of General Psychiatry",47, 3,1,0,0,0,0,0,1
1990,"Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal","Glue P., Nutt D.",00071250,"British Journal of Psychiatry",157, ,45,2,2,1,5,0,50
1990,"Closure of MRC units","Nutt D.",01406736,"Lancet",336, 8719,0,0,0,0,0,0,0
1990,"Not only but also? Comments on 'How does convulsive therapy work?'","Nutt D.",0893133X,"Neuropsychopharmacology",3, 2,1,0,1,0,1,0,2
1990,"The neurochemistry of anxiety: An update","Nutt D.J., Glue P., Lawson C.",02785846,"Progress in Neuro-Psychopharmacology and Biological Psychiatry",14, 5,28,4,1,0,5,0,33
1990,"Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide","Roy A., Lamparski D., De Jong J., Adinoff B., Ravitz B., George D.T., Nutt D., Linnoila M.",0001690X,"Acta Psychiatrica Scandinavica",81, 1,16,1,2,0,3,0,19
1990,"Flumazenil provocation of panic attacks: Evidence for altered benzodiazepine receptor sensitivity in panic disorder","Nutt D.J., Glue P., Lawson C., Wilson S.",0003990X,"Archives of General Psychiatry",47, 10,152,3,5,1,9,0,161
1990,"Behaviour, autonomic function and the brain","Nutt D.J.",09517383,"Current Opinion in Neurology and Neurosurgery",3, 4,0,0,0,0,0,0,0
1990,"Intoxicating addiction: Aspects of the psychopharmacology of alcoholism. Meeting report, annual congress of medicine, Helsinki January 1990","Nutt D.",02698811,"Journal of Psychopharmacology",4, 2,0,0,0,0,0,0,0
1990,"Editorial","Nutt D.",02698811,"Journal of Psychopharmacology",4, 3,0,0,0,0,0,0,0
1990,"Does electroconvulsive shock therapy work through opioid mechanisms?","Jackson H.C., Nutt D.J.",08856222,"Human Psychopharmacology",5, 1,0,0,0,0,0,0,0
1990,"Alcoholism and panic disorder: Is the comorbidity more than coincidence?","George D.T., Nutt D.J., Dwyer B.A., Linnoila M.",0001690X,"Acta Psychiatrica Scandinavica",81, 2,61,1,2,0,3,0,64
1990,"Pharmacological mechanisms of benzodiazepine withdrawal","Nutt D.J.",00223956,"Journal of Psychiatric Research",24, 2,14,1,0,0,1,0,15
1989,"Exploring ?-receptor function using the selective opioid antagonist naltrindole","Jackson H.C., Ripley T.L., Nutt D.J.",00283908,"Neuropharmacology",28, 12,18,0,0,0,0,0,18
1989,"Attitudes to anxiety.","Nutt D., Lawson C., Glue P.",00071250,"British Journal of Psychiatry",155, ,0,0,0,0,0,0,0
1989,"Endocrine response to syncope in panic disorder","Nutt D.J.",01651781,"Psychiatry Research",28, 3,4,0,0,0,0,0,4
1989,"Low affinity hypothalamic [3H]mazindol binding: A probe for hypothalamic body weight regulation?","Gleiter C.H., Linnoila M., Nutt D.J.",01956663,"Appetite",12, 2,0,0,0,0,0,0,0
1989,"Effect of single and repeated electroconvulsive shock on body temperature in mice","Gleiter C.H., Costello M.J., Nutt D.J.",07498055,"Convulsive Therapy",5, 2,4,0,0,0,0,0,4
1989,"Monoamine oxidase inhibitors: Rehabilitation from recent research?","Nutt D., Glue P.",00071250,"British Journal of Psychiatry",154, ,6,0,1,0,1,0,7
1989,"Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective","Nutt D.J., Glue P.",01637258,"Pharmacology and Therapeutics",44, 3,29,1,1,0,2,0,31
1989,"Panic response to lactate administration in alcoholic and nonalcoholic patients with panic disorder","George D.T., Nutt D.J., Waxman R.P., Linnoila M.",0002953X,"American Journal of Psychiatry",146, 9,7,0,0,0,0,0,7
1989,"Aggressive thoughts and behavior: another symptom of panic disorder?","George D.T., Anderson P., Nutt D.J., Linnoila M.",0001690X,"Acta Psychiatrica Scandinavica",79, 5,14,0,0,0,0,0,14
1989,"3-(Methoxycarbonyl)-amino-?-carboline reduces both the sedative and anticonvulsant effects of diazepam","Nutt D.J., Lister R.G.",00142999,"European Journal of Pharmacology",165, 1,2,0,0,0,0,0,2
1989,"Chronic electroconvulsive shock and neurotransmitter receptors. An update","Gleiter C.H., Nutt D.J.",00243205,"Life Sciences",44, 15,23,1,0,0,1,0,24
1989,"Lactate and hyperventilation substantially attenuate vagal tone in normal volunteers. A possible mechanism of panic provocation?","George D.T., Nutt D.J., Walker W.V., Porges S.W., Adinoff B., Linnoila M.",0003990X,"Archives of General Psychiatry",46, 2,51,3,2,0,5,0,56
1989,"Neurochemical insights into alcohol kindling","Nutt D.J., Glue P.",08856222,"Human Psychopharmacology",4, 3,1,0,0,0,0,0,1
1989,"Neuropharmacological aspects of ECT: In search of the primary mechanism of action","Nutt D.J., Gleiter C.H., Glue P.",07498055,"Convulsive Therapy",5, 3,3,0,0,0,0,0,3
1989,"Benzodiazepines in the treatment of alcoholism.","Nutt D., Adinoff B., Linnoila M.",0738422X,"Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism",7, ,16,2,0,0,2,0,18
1989,"Effect of single and repeated electroconvulsive shock on the hypothalamic-pituitary-adrenal axis and plasma catecholamines in rats","Thiagarajan A.B., Gleiter C.H., Mefford I.N., Eskay R.L., Nutt D.J.",00333158,"Psychopharmacology",97, 4,12,0,0,0,0,0,12
1989,"A comparison of calcium antagonists and diazepam in reducing ethanol withdrawal tremors","Bone G.H.A., Majchrowicz E., Martin P.R., Linnoila M., Nutt D.J.",00333158,"Psychopharmacology",99, 3,17,1,0,2,3,0,20
1989,"Studies of alpha-2-adrenoceptor function in abstinent alcoholics","Glue P., Sellmann J.D., Nicholls M.G., Abbott R., Joyce P.R., Nutt D.J.",09520481,"British Journal of Addiction",84, 1,15,0,0,0,0,0,15
1989,"Electroconvulsive shock (ECS) and the adenosine neuromodulatory system: Effect of single and repeated ECS on the adenosine A1 and A2 receptors, adenylate cyclase, and the adenosine uptake site","Gleiter C.H., Deckert J., Nutt D.J., Marangos P.J.",00223042,"Journal of Neurochemistry",52, 2,22,0,0,0,0,0,22
1989,"Attenuation of ethanol intoxication by alpha-2 adrenoceptor antagonists","Lister R.G., Durcan M.J., Nutt D.J., Linnoila M.",00243205,"Life Sciences",44, 2,5,0,0,0,0,0,5
1989,"Altered central ?2-adrenoceptor sensitivity in panic disorder","Nutt D.J.",0003990X,"Archives of General Psychiatry",46, 2,54,1,2,1,4,0,58
1988,"Alpha-2-adrenoceptor function in alcoholics","Nutt D.J., Glue P.",02703106,"Advances in Alcohol and Substance Abuse",7, 3-4,1,0,0,0,0,0,1
1988,"Aspects of alpha-2-adrenoreceptor function in normal volunteers","Nutt D.J., Glue P.",08856222,"Human Psychopharmacology",3, 4,2,0,0,0,0,0,2
1988,"Alcohol anxiety and phobias","Nutt D.J.",09517367,"Current Opinion in Psychiatry",1, 3,0,0,0,0,0,0,0
1988,"Measuring the serotonin uptake site using [3H]paroxetine - A new serotonin uptake inhibitor","Gleiter C.H., Nutt D.J.",02703106,"Advances in Alcohol and Substance Abuse",7, 3-4,0,0,0,0,0,0,0
1988,"Antagonizing the behavioral effects of ethanol using drugs that act at the benzodiazepine/GABA receptor macromolecular complex","Lister R.G., Nutt D.J.",00913057,"Pharmacology Biochemistry and Behavior",31, 3,2,0,0,0,0,0,2
1988,"Clonidine challenge testing of alpha-2-adrenoceptor function in man: The effects of mental illness and psychotropic medication","Glue P., Nutt D.",02698811,"Journal of Psychopharmacology",2, 3-4,6,0,1,0,1,0,7
1988,"RO 15-4513 and its interaction with ethanol","Lister R.G., Nutt D.J.",02703106,"Advances in Alcohol and Substance Abuse",7, 3-4,2,1,1,0,2,0,4
1988,"Circadian rhythms of cortisol during alcohol withdrawal","Risher-Flowers D., Adinoff B., Ravitz B., Bone G.H.A., Martin P.R., Nutt D., Linnoila M.",02703106,"Advances in Alcohol and Substance Abuse",7, 3-4,20,0,0,0,0,0,20
1988,"The effect of acute and chronic electroconvulsive shock on [ 3H]Phorbol-dibutyrate binding to rat brain membranes","Gleiter Ch. H., Deckert J., Nutt D.J., Marangos P.J.",03643190,"Neurochemical Research",13, 11,3,0,0,0,0,0,3
1988,"Antagonizing the anticonvulsant effect of ethanol using drugs acting at the benzodiazepine/GABA receptor complex","Nutt D.J., Lister R.G.",00913057,"Pharmacology Biochemistry and Behavior",31, 3,9,0,0,0,0,0,9
1988,"Electroconvulsive shock does not increase plasma insulin in rats","Thiagarajan A.B., Gleiter C.H., Nutt D.J.",07498055,"Convulsive Therapy",4, 4,1,0,1,0,1,0,2
1988,"A technique for chronic catheterization of the cisterna magna in rabbits.","Glue P., Bacher J.D., Nutt D.J.",00236764,"Laboratory animal science",38, 6,2,0,0,0,0,0,2
1988,"Possible receptor mechanisms underlying tolerance and withdrawal","Nutt D.",02683091,"Round Table Series - Royal Society of Medicine",, 11,0,0,0,0,0,0,0
1988,"Neuroreceptor science: A clarification of terms","Nutt D.J., Linnoila M.",02710749,"Journal of Clinical Psychopharmacology",8, 6,0,0,0,0,0,0,0
1988,"Benzodiazepine terminology","Nutt D.",01656147,"Trends in Pharmacological Sciences",9, 3,0,0,0,0,0,0,0
1988,"Alcohol antagonists - The continuing quest","Lister R.G., Nutt D.J.",01456008,"Alcoholism: Clinical and Experimental Research",12, 4,4,0,0,0,0,0,4
1988,"Heart rate response to standing as an index of adaptation to imipramine during treatment of panic disorder","Middleton H.C., Nutt D.J.",08856222,"Human Psychopharmacology",3, 3,2,0,0,0,0,0,2
1988,"Repeated electroconvulsive shock normalizes blood glucose levels in genetically obese mice (C57BL/6J ob/ob) but not in genetically diabetic mice (C57BL/KsJ db/db)","Nutt D.J., Gleiter C.H., Linnoila M.",00068993,"Brain Research",448, 2,4,0,0,0,0,0,4
1988,"Chronic benzodiazepine treatment increases the effects of the inverse agonist FG7142","Little H.J., Gale R., Sellars N., Nutt D.J., Taylor S.C.",00283908,"Neuropharmacology",27, 4,14,0,0,0,0,0,14
1988,"A single electroconvulsive shock substantially lowers blood glucose levels in obese mice (C57BL/6J ob/ob)","Gleiter C.H., Nutt D.J.",00333158,"Psychopharmacology",95, 2,0,0,0,0,0,0,0
1988,"Strain differences in response to a benzodiazepine receptor inverse agonist (FG 7142) in mice.","Nutt D.J., Lister R.G.",00333158,"Psychopharmacology",94, 3,6,0,0,0,0,0,6
1988,"Neurochemical studies in normal volunteers","Nutt D.J., Cowen P.J.",02650673,"Pharmaceutical Medicine",3, 1,0,0,0,0,0,0,0
1988,"Rapid induction of lorazepam dependence and reversal with flumazenil","Nutt D.J., Costello M.J.",00243205,"Life Sciences",43, 13,14,0,0,0,0,0,14
1988,"Letters to editors. Binge use of benzodiazepines","Nutt D., Ravitz B., Risher-Flowers D.",08856222,"Human Psychopharmacology",3, 3,0,0,0,0,0,0,0
1988,"?-2-Adrenoreceptor function in alcohol withdrawal: A pilot study of the effects of IV clonidine in alcoholics and normals","Nutt D., Glue P., Molyneux S., Clark E.",01456008,"Alcoholism: Clinical and Experimental Research",12, 1,28,0,1,1,2,0,30
1988,"Evidence that imipramine-induced postural hypotension may be centrally mediated","Middleton H.C., Nutt D.J., Anastassiades P.",08856222,"Human Psychopharmacology",3, 3,1,0,0,0,0,0,1
1988,"Interactions of the imidazodiazepine Ro 15-4513 with chemical convulsants","Lister R.G., Nutt D.J.",00071188,"British Journal of Pharmacology",93, 1,3,0,0,0,0,0,3
1988,"Repeated electroconvulsive shock increases the number of [3H]desipramine binding sites in rat cerebral cortex","Gleiter C.H., Nutt D.J.",00333158,"Psychopharmacology",96, 3,2,0,0,0,0,0,2
1988,"Repeated electroconvulsive shock does not change [3H]-paroxetine binding to the 5-HT uptake site in rat cortical membranes","Gleiter C.H., Nutt D.J.",00333158,"Psychopharmacology",95, 1,8,0,0,0,0,0,8
1988,"The hypothermic response to clonidine is absent in alcohol withdrawal but returns in abstinence","Glue P., Sellman J.D., Joyce P.R., Nicholls M.G., Nutt D.J.",00063223,"Biological Psychiatry",24, 1,4,0,0,0,0,0,4
1988,"Changes in benzodiazepine/GABA receptor complex function in benzodiazepine-tolerant mice","Nutt D.J., Taylor S.C., Little H.J., Standing B.L., Gale R.G.",00333158,"Psychopharmacology",95, 3,2,0,0,0,0,0,2
1988,"RO 15-4513 does not protect rats against the lethal effects of ethanol","Nutt D.J., Lister R.G., Rusche D., Bonetti E.P., Reese R.E., Rufener R.",00142999,"European Journal of Pharmacology",151, 1,1,0,1,0,1,0,2
1988,"Strain differences in response to a benzodiazepine receptor inverse agonist (FG 7142) in mice","Nutt D.J., Lister R.G.",00333158,"Psychopharmacology",94, 3,7,1,0,0,1,0,8
1988,"Changes in caffeine seizure threshold after electroconvulsive shock","Gleiter C.H., Deckert J., Nutt D.J.",00333158,"Psychopharmacology",95, 4,0,0,0,0,0,0,0
1988,"Panic attacks and alcohol withdrawal: Can subjects differentiate the symptoms?","George D.T., Zerby A., Noble S., Nutt D.J.",00063223,"Biological Psychiatry",24, 2,19,0,0,0,0,0,19
1987,"Kindling and withdrawal changes at the benzodiazepine receptor","Little H.J., Nutt D.J., Taylor S.C.",02698811,"Journal of Psychopharmacology",1, 1,5,0,0,0,0,0,5
1987,"Alcohol withdrawal and noradrenergic function","Linnoila M., Mefford I., Nutt D., Adinoff B.",00034819,"Annals of Internal Medicine",107, 6,57,3,4,0,7,0,64
1987,"Bidirectional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor","Little H.J., Nutt D.J., Taylor S.C.",03619230,"Brain Research Bulletin",19, 3,15,0,0,1,1,0,16
1987,"The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan","Idzikowski C., Cowen P.J., Nutt D., Mills F.J.",00333158,"Psychopharmacology",93, 4,13,3,0,0,3,0,16
1987,"Platelet monamine receptor binding in alcoholics during withdrawal","Nutt D., Glue P., Stewart A.",09520481,"British Journal of Addiction",82, 11,0,0,0,0,0,0,0
1987,"Clonidine in alcohol withdrawal: a pilot study of differential symptom responses following I.V. clonidine","Glue P., Nutt D.",03091635,"Alcohol and Alcoholism",22, 2,4,0,0,0,0,0,4
1987,"The neuroendocrine effects of oral imipramine","Nutt D., Middleton H., Franklin M.",03064530,"Psychoneuroendocrinology",12, 5,16,1,0,0,1,0,17
1987,"Benzodiazepines, plasma MHPG and alpha-2-adrenoceptor function in man.","Nutt D., Molyneux S.",02681315,"International Clinical Psychopharmacology",2, 2,5,0,0,0,0,0,5
1987,"The effect of the imidazodiazepine Ro 15-4513 on the anticonvulsant effects of diazepam, sodium pentobarbital and ethanol","Nutt D.J., Lister R.G.",00068993,"Brain Research",413, 1,5,0,0,0,0,0,5
1987,"Platelet binding studies in panic disorder","Nutt D.J., Fraser S.",01650327,"Journal of Affective Disorders",12, 1,9,1,1,0,2,0,11
1987,"Platelet ?2-adrenoceptor binding does not predict brain ?2-adrenoceptor function","Nutt D.J.",03065251,"British Journal of Clinical Pharmacology",24, 1,1,0,0,0,0,0,1
1987,"Selective effect of lithium on cognitive performance in man","Glue P.W., Nutt D.J., Cowen P.J., Broadbent D.",00333158,"Psychopharmacology",91, 1,10,0,0,0,0,0,10
1987,"Benzodiazepine-serotonin interactions in man.","Nutt D.J., Cowen P.J.",09316795,"Psychopharmacology series",3, ,1,0,0,0,0,0,1
1987,"Is RO 15-4513 a specific alcohol antagonist?","Lister R.G., Nutt D.J.",01662236,"Trends in Neurosciences",10, 6,16,1,0,0,1,0,17
1987,"Effect of pregnancy on panic attacks","George D.T., Ladenheim J.A., Nutt D.J.",0002953X,"American Journal of Psychiatry",144, 8,39,2,0,0,2,0,41
1987,"A single dose of FG 7142 causes long-term increases in mouse cortical ?-adrenoceptors","Stanford S.C., Little H.J., Nutt D.J., Taylor S.C.",00142999,"European Journal of Pharmacology",134, 3,6,0,0,0,0,0,6
1987,"Selective changes in the in vivo effects of benzodiazepine receptor ligands after chemical kindling with FG 7142","Little H.J., Nutt D.J., Taylor S.C.",00283908,"Neuropharmacology",26, 1,7,0,0,0,0,0,7
1987,"Diazepam alters brain 5-HT function in man: Implications for the acute and chronic effects of benzodiazepines","Nutt D.J., Cowen P.J.",00332917,"Psychological Medicine",17, 3,16,1,0,0,1,0,17
1987,"Flumazenil and benzodiazepine withdrawal","Nutt D., Costello M., Ball J.A.",01406736,"Lancet",2, 8556,0,0,0,0,0,0,0
1986,"The effect of clonidine on plasma MHPG: Evidence against tonic alpha2-adrenoceptor control of noradrenergic function","Nutt D.J., Molyneux S.G.",00333158,"Psychopharmacology",90, 4,0,0,1,0,1,0,1
1986,"Benzodiazepine-receptor mediated convulsions in infant rats: Effects of beta-carbolines","Nutt D.J., Little H.",00913057,"Pharmacology Biochemistry and Behavior",24, 4,1,0,0,0,0,0,1
1986,"Performance effects of diazepam during and after prolonged administration","Brosan L., Broadbent D., Nutt D., Broadbent M.",00332917,"Psychological Medicine",16, 3,9,0,0,0,0,0,9
1986,"Benzodiazepine dependence in the clinic: reason for anxiety?","Nutt D.",01656147,"Trends in Pharmacological Sciences",7, C,15,0,0,0,0,0,15
1986,"Increased sexual function in benzodiazepine withdrawal","Nutt D., Hackman A., Hawton K.",01406736,"Lancet",2, 8515,0,0,0,0,0,0,0
1986,"European winter conference on brain research. Vars-les-Claux, France March 11-16, 1985 Proceedings from workshop on 'Benzodiazepines, 5-HT & anxiety'","Nutt D.J., File S.E.",00913057,"Pharmacology, Biochemistry and Behavior",24, 5,0,0,0,0,0,0,0
1986,"Monoamines and alcohol","Nutt D., Glue P.",09520481,"British Journal of Addiction",81, 3,10,1,0,0,1,0,11
1986,"Mice and rats are sensitized to the proconvulsant action of a benzodiazepine-receptor inverse agonist (FG 7142) following a single dose of lorazepam","Lister R.G., Nutt D.J.",00068993,"Brain Research",379, 2,7,0,0,0,0,0,7
1986,"The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors","Glue P.W., Cowen P.J., Nutt D.J.",00333158,"Psychopharmacology",90, 3,16,1,0,0,1,0,17
1986,"Increased central alpha2-adrenoceptor sensitivity in panic disorder","Nutt D.J.",00333158,"Psychopharmacology",90, 2,5,1,1,0,2,0,7
1986,"Effects of chronic treatment with benzodiazepine receptor ligands on cortical adrenoceptors","Stanford S.C., Little H.J., Nutt D.J., Taylor S.C.",00142999,"European Journal of Pharmacology",129, 1-2,3,0,1,0,1,0,4
1986,"The effect of diazepam on indices of 5-HT function in man","Nutt D.J., Cowen P.J., Franklin M.",00913057,"Pharmacology Biochemistry and Behavior",24, 5,1,0,0,1,1,0,2
1986,"The effects of drugs acting at the GABA(A)-receptor/ionophore after chemical kindling with the benzodiazepine receptor ligand FG 7142","Little H.J., Nutt D.J., Taylor S.C.",00071188,"British Journal of Pharmacology",88, 3,4,1,1,0,2,0,6
1986,"Optimizing the pentetrazol infusion test for seizure threshold measurement","Nutt D.J., Taylor S.C., Little H.J.",00223573,"Journal of Pharmacy and Pharmacology",38, 9,14,0,0,0,0,0,14
1985,"A benzodiazepine agonist and contragonist have hypothermic effects in rodents","Taylor S.C., Little H.J., Nutt D.J., Sellars N.",00283908,"Neuropharmacology",24, 1,5,0,2,0,2,0,7
1985,"The benzodiazepine antagonist, Ro 15-1788 does not decrease ethanol withdrawal convulsions in rats","Little H.J., Taylor S.C., Nutt D.J., Cowen P.J.",00142999,"European Journal of Pharmacology",107, 3,2,0,0,0,0,0,2
1984,"Acute and chronic effects of the benzodiazepine receptor ligand FG 7142: Proconvulsant properties and kindling","Little H.J., Nutt D.J., Taylor S.C.",00071188,"British Journal of Pharmacology",83, 4,37,0,1,1,2,0,39
1984,"The effect of repeated electroconvulsive shock on the function of THIP, a GABA agonist","Minchin M.C.W., Nutt D.J.",00913057,"Pharmacology Biochemistry and Behavior",21, 4,0,0,0,0,0,0,0
1984,"On the convulsant action of Ro 5-4864 and the existence of a micromolar benzodiazepine binding site in rat brain","File S.E., Green A.R., Nutt D.J., Vincent N.D.",00333158,"Psychopharmacology",82, 3,3,0,0,1,1,0,4
1984,"Investigating benzodiazepine receptor function in vivo using an intravenous infusion of DMCM","Nutt D.J., Little H.J., Taylor S.C., Minchin M.C.W.",00142999,"European Journal of Pharmacology",103, 3-4,5,0,0,0,0,0,5
1983,"Pharmacological and behavioural studies of benzodiazepine antagonists and contragonists.","Nutt D.",00652229,"Advances in biochemical psychopharmacology",38, ,1,1,0,0,1,0,2
1983,"Studies on [3H]diazepam and [3H]ethyl-?-carboline carboxylate binding to rat brain in vivo. I. Regional variations in displacement","Minchin M.C.W., Nutt D.J.",00223042,"Journal of Neurochemistry",41, 6,0,0,0,0,0,0,0
1983,"Thyroid hormones do not alter rat brain benzodiazepine receptor function in-vivo","Atterwill C.K., Nutt D.J.",00223573,"Journal of Pharmacy and Pharmacology",35, 11,1,0,0,0,0,0,1
1983,"Studies on [3H]diazepam and [3H]ethyl-?-carboline carboxylase binding to rat brain in vivo. II. Effects of electroconvulsive shock","Nutt D.J., Minchin M.C.W.",00223042,"Journal of Neurochemistry",41, 6,0,0,0,0,0,0,0
1983,"Hypophysectomy alters both 5-hydroxytryptamine- and ?2-adrenoceptor-mediated behavioural changes in the rat","Heal D.J., O'Shaughnessy K.M., Smith S.L., Nutt D.J.",00142999,"European Journal of Pharmacology",89, 1-2,1,0,0,0,0,0,1
1983,"Repeated electroconvulsive shock alters diazepam pharmacokinetics in rats","Davies C.L., Nutt D.J.",00071188,"British Journal of Pharmacology",78, ,0,0,0,0,0,0,0
1983,"Comparison of the effects of chronic desmethylimipramine administration on ?2- and ?-adrenoceptors in different regions of rat brain","Stanford C., Nutt D.J., Cowen P.J.",03064522,"Neuroscience",8, 1,9,0,0,0,0,0,9
1983,"Regional GABA concentration and [3H]-diazepam binding in rat brain following repeated electroconvulsive shock","Bowdler J.M., Green A.R., Minchin M.C.W., Nutt D.J.",,"Journal of Neural Transmission - General Section",56, 1,9,2,0,0,2,0,11
1982,"Using Ro 15-1788 to investigate the benzodiazepine receptor in vivo: Studies on the anticonvulsant and sedative effect of melatonin and the convulsant effect of benzodiazepine Ro 05-3663","Green A.R., Nutt D.J., Cowen P.J.",00333158,"Psychopharmacology",78, 3,12,0,0,0,0,0,12
1982,"Intrinsic actions of benzodiazepine antagonists","File S.E., Lister R.G., Nutt D.J.",03043940,"Neuroscience Letters",32, 2,10,0,0,0,0,0,10
1982,"The anxiogenic action of benzodiazepine antagonists","File S.E., Lister R.G., Nutt D.J.",00283908,"Neuropharmacology",21, 10,44,1,2,0,3,0,47
1982,"Repeated administration of subconvulsant doses of GABA antagonist drugs. II. Effect on monoamine-mediated behavior","Cowen P.J., Nutt D.J., Batts C.C.",00333158,"Psychopharmacology",76, 1,0,0,0,0,0,0,0
1982,"Hypophysectomy does not prevent the enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shocks","Nutt D.J., Smith S.L., Heal D.J.",00283908,"Neuropharmacology",21, 9,0,0,0,0,0,0,0
1982,"Unusual interactions of benzodiazepine receptor antagonists","Nutt D.J., Cowen P.J., Little H.J.",00280836,"Nature",295, 5848,22,1,0,0,1,0,23
1982,"Comparison of the effects of repeated electroconvulsive shock on ?2- and ?-adrenoceptors in different regions of rat brain","Stanford S.C., Nutt D.J.",03064522,"Neuroscience",7, 7,13,0,0,0,0,0,13
1982,"Repeated administration of subconvulsant doses of GABA antagonist drugs. I. Effect on seizure threshold (kindling)","Nutt D.J., Cowen P.J., Batts C.C.",00333158,"Psychopharmacology",76, 1,11,1,1,0,2,0,13
1982,"Abstinence symptoms after withdrawal of tranquillising drugs: is there a common neurochemical mechanism?","Cowen P.J., Nutt D.J.",01406736,"Lancet",2, 8294,8,0,0,1,1,0,9
1981,"Decreased ?2-adrenoceptor numbers in rat brain following repeated electro-convulsive shock","Nutt D., Stanford C.",00071188,"British Journal of Pharmacology",74, 4,0,0,0,0,0,0,0
1981,"Effects of repeated electro-convulsive shock on ?-adrenergic receptors in rat brain","Nutt D., Stanford C.",00223751,"Journal of Physiology",320, ,0,0,0,0,0,0,0
1981,"Drug-induced alterations of the post-ictal seizure threshold increase","Cowen P.J., Green A.R., Nutt D.J.",00071188,"British Journal of Pharmacology",73, 1,0,0,0,0,0,0,0
1981,"Studies on the post-ictal rise in seizure threshold","Nutt D.J., Cowen P.J., Green A.R.",00142999,"European Journal of Pharmacology",71, 2-3,11,2,0,0,2,0,13
1981,"Ethyl ?-carboline carboxylate lowers seizure threshold and antagonizes flurazepam-induced sedation in rats","Cowen P.J., Green A.R., Nutt D.J.",00280836,"Nature",290, 5801,12,0,2,0,2,0,14
1980,"Altered monoamine-mediated behaviours following bicuculline-induced convulsions","Green A.R., Nutt D.J.",00071188,"British Journal of Pharmacology",70, 1,0,0,0,0,0,0,0
1980,"On the measurement in rats of the convulsant effect of drugs and the changes which follow electroconvulsive shock","Nutt D.J., Green A.R.",00283908,"Neuropharmacology",19, 10,2,1,0,0,1,0,3
1980,"Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions - II. The effects of anaesthesia and current conditions on the appearance of enhanced responses following electroconvulsive shock","Cowen P.J., Nutt D.J., Green A.R.",00283908,"Neuropharmacology",19, 9,2,1,0,0,1,0,3
1980,"Effect of anaesthetic administration on the appearance of enhanced monoamine-mediated behaviours following electroconvulsive shock","Cowen P.J., Green A.R., Nutt D.J.",00071188,"British Journal of Pharmacology",70, 1,0,0,0,0,0,0,0
1980,"Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions - I. The effects of single and repeated bicuculline-induced seizures.","Nutt D.J., Green A.R., Grahame-Smith D.G.",00283908,"Neuropharmacology",19, 9,1,0,0,0,0,0,1
1980,"Repeated electroconvulsive shock does not increase the susceptibility of rats to a cage convulsant (Isopropylbicyclophosphate)","Cowen P.J., Nutt D.J., Green A.R.",00283908,"Neuropharmacology",19, 10,0,0,0,0,0,0,0
